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ABSTRACT 
 
Ejaculatory dysfunction after spinal cord injury (SCI) is common with 
more than 90% of SCI men unable to produce an ejaculate. If the 
ejaculate is obtained by vibro or electro ejaculation the motility, 
morphology and forward progression are all subnormal. The exact 
cause of deterioration of sperms is not known although a number of 
factors can lead to poor quality semen.  
 
A randomized control trial was designed to evaluate if repeated 
ejaculation with a Ferticare® vibrator can improve the sperm quality 
in chronic SCI men. All had a spinal cord lesion above thoracic level 
10 with a minimum duration of 6 months. The subjects who vibro-
ejaculated (VE) with a Ferticare® vibrator were randomised into the 
study or control arms. In the study arm VE was applied weekly for 3 
months. In the control arm VE was given only once at the beginning 
and end of 3 months. The semen analysis was performed by two 
observers according to World Health Organization (WHO) criteria. A 
paired Student t test was used for statistical analysis. 
 
Forty two of 79 subjects (53%) vibro-ejaculated successfully. Thirty 
four were randomized into study (n=18) and control (n=16) arms. No 
serious adverse events were encountered. Only morphology and 
forward progression on WHO criteria demonstrated significant 
improvement. There was no statistical improvement in either volume, 
count or motility. 
 
It is concluded that repeated ejaculation can improve some 
parameters of sperm in the semen of SCI men. Hence, patients with 
a SCI above the level of T10 can improve their sperm quality by 
applying VE weekly for at least 3 months.  
 
It is hoped that larger scale multi-centre studies will be undertaken to 
confirm the effectiveness of repeated ejaculations.  
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1- INTRODUCTION 
 
1.1 Spinal Cord Injury – Introduction 
 
Spinal cord injury (SCI) is a universal condition with an annual 
incidence of 15 to 40 cases per million(1). The mortality from acute 
SCI is steadily declining.  A patient will spend, on average, 6 months 
in the first 2 years following the injury in a hospital (1). In the UK 
there are an estimated 1000 new SCI per annum (www.spinal-
injury.net). 
More than half of the SCI are related to traffic accidents(2). 55% of 
the patients sustain injury at the cervical level with the rest divided 
equally between thoracic, thoracic lumbar and lumbar sacral levels.  
About half of these patients have complete transection of the spinal 
cord. However, this trend is changing and now an increasing number 
of patients sustain incomplete injuries at thoracolumbar level(3;4).  
The injuries at the thoracic level are more complete than cervical or 
lumbar ones. About 70% of the SCI are sustained between the ages 
of 11 and 50 years and crucially 80% to 85% of these are 
male(2;5;6).   
 
Up to 95% of these men can have ejaculatory failure. Combined with 
erectile dysfunction and poor sperm quality, which are both very 
common in SCI as well, this problem takes on significant dimensions. 
Infertility is a common problem in men following SCI (7). Considering 
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the younger average age of patients with SCI (7) and the desire to 
have a family in most men (8) the consequences of not being able to 
father children can be devastating. 
 
The last century has seen a vast improvement in the length and 
quality of life after spinal cord injury (1), but unfortunately, infertility 
remains a major concern(7). The majority of SCI occur in men in their 
reproductive years (7). Even if the patient is not planning to start a 
family the loss of ability to procreate is difficult to accept, sexually 
non-active SCI men have shown decreased ability to engage in 
vocational training (9).  
 
Male infertility is attributed to erectile dysfunction and poor semen 
quality. Horne (10) reported erections in 74% of men with SCI whilst 
only 18% achieving ejaculations. Erections either reflexogenic or 
psychogenic will be achieved in 85% of men 2 years after SCI (11). 
The estimated rate of successful sexual intercourse ranges between 
5% and 75% after SCI(11). Historically, Bors(12) in 1960 reported an 
ejaculation rate of only 5% for men with complete upper motor 
neuron lesions that increased to 32% if the lesion was incomplete. 
Patients with complete lower motor neuron lesions (conus and 
complete cauda equina lesions) reported an ejaculation rate of 18% 
while 70% with incomplete lower motor neuron lesions could 
ejaculate(12). In line with the observations by Bors, more recently 
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Sonksen(13) reported an ejaculatory failure rate of up to 90% in men 
with SCI. 
 
Despite improvements in semen retrieval methods with vibro-
ejaculation (VE) and electro-ejaculation (EEJ) the quality of sperms is 
consistently poor in all series evaluating semen in SCI patients(14-
18). Sperm motility and morphology are especially abnormal. It was 
initially thought that there was no difference in the quality of semen 
regardless of the technique of sperm retrieval (19). However, later 
studies demonstrated that the semen obtained by VE is of better 
quality than that obtained by EEJ (20;21). Although, the various 
harvesting techniques may yield large numbers of sperm they are 
generally of very low motility. Overall, 7.5% of SCI patients will have 
a normal semen analysis according to World Health Organisation 
(WHO) criteria (22), around 10% will be azospermic with the 
remainder having abnormal semen quality(23). Hence an 
overwhelming majority of SCI men will have an abnormal semen 
quality for as yet poorly understood reasons(24). 
 
As the exact cause of the poor motility cannot be ascertained, at 
present there is no definite way to improve the quality of sperms. 
Currently, the only available technique to retrieve semen by the 
patient himself is VE (25). The semen thus obtained can be used for 
intravaginal insemination at home by the patient and his partner. 
Other techniques for semen retrieval like EEJ or testicular 
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procedures require a physician. The semen obtained by these 
methods can only be utilised with assisted conceptions techniques in 
a fertility clinic with all the associated costs. Unfortunately, there is no 
guarantee that these expensive methods will work effectively. Hence, 
the procedure is often abandoned much to the disappointment of the 
patient and results in financial loss. 
 
The semen characteristics of SCI men are unique with a normal 
sperm concentration. a low motility and denervation of the accessory 
glands (7). Although, the normal reference range for sperm 
concentration as per WHO manual in 1999 was 20 X 106 per ml or 
more, there can be considerable variation in the samples from the 
same man (22). This can be related to the period of abstention, 
febrile illnesses or medications. However, the variation can be 
detected even without any apparent cause (22). This variation is all 
the more marked in SCI men (7). The exact cause of this variation is 
still not known but is thought to be multifactorial. All these factors 
lead to an abnormal seminal plasma environment. Overall, the 
treatments for non SCI infertile men are effective to a similar degree 
in assisting conception in SCI men(7).   
 
The full impact of SCI on sexual function is not fully appreciated. In a 
survey of more than 2500 men with SCI the rate of ejaculation with 
sexual stimulation or masturbation varied from 0-55% with a median 
of only 15%(13).  However, 54% to 95% were able to attain 
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spontaneous erections to some degree(26). The exact cause of 
ejaculatory failure is not known but is thought to be related to 
interruption of the co-ordinated response of the autonomic and 
somatic nervous system via sympathetic and pudendal pathways 
respectively.      
 
The rate of spontaneous fertility in SCI patients is about 5%(27). The 
reported rate with intravaginal and intrauterine insemination is 25% to 
61% per treatment cycle (28;29). This drops to about 25% with 
assisted fertilization techniques(30;31) and is largely dependent on 
the quality of sperms especially with assisted techniques. 
 
1.2 Normal sperm production and ejaculatory function 
 
The sperms are produced in the testis under hormonal influence from 
the pituitary gland and are transported to the ejaculatory ducts under 
the influence of the autonomic and somatic nervous systems. 
 
1.2.1 Normal Sperm Production 
 
Sperm production takes place in the testis under the influence of the 
pituitary-gonadal hormonal axis. The anterior pituitary secretes 
follicle stimulating hormone (FSH) which stimulates sertoli cells to 
activate spermatogenesis, whilst luteinizing hormone (LH) acts on 
leydig cells to produce testosterone(32). The testicular temperature is 
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2 – 4 degrees below the rectum due to the counter current exchange 
mechanism of the blood vessels(33). The spermatogenesis takes 
place in the germinal epithelium of the testis. The process takes 64 
days in humans(34). Spermatozoa at this stage are immotile and 
only have a limited capability to fertilize the ovum. Final maturation 
takes place during the epididymal transit which takes between 2 to 
11 days(35). The sperms are stored in the caudal part of epididymis 
for varying lengths of time depending upon the sexual activity. It has 
been shown that the forward progression of sperms improves during 
the transit through epididymis (36). The spermatozoa are rapidly 
transported from the distal epididymis to the ejaculatory ducts just 
before emission by strong contractions of the vas deferens. This is 
under sympathetic innervation(37).    
 
1.2.2 Neuro-anatomy of Ejaculatory function  
 
The neural innervation for sexual co-ordination is intricately 
associated with the limb girdle plexus. This consists of dorsal and 
ventral rami from the lumbar and sacral plexus along with 
sympathetic and parasympathetic pathways formed into complicated 
nerves supplying both the lower limbs and the pelvic viscera. The 
general outlay of lumbosacral plexuses relevant to ejaculatory 
function is shown in figure 1.1. The ejaculation is mediated by both 
autonomic (sympathetic & parasympathetic) and somatic (pudendal) 
nervous systems.  
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Figure 1.1: The afferent and efferent nerve fibres involved in 
ejaculation (38) 
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1.2.3 Autonomic Nervous System 
 
The sympathetic nervous system participates in ejaculatory function 
by contributions from 11th Thoracic (T) to 2nd lumbar (L) 
segments(39). The preganglionic cell bodies are located in the 
intermediolateral parts of the spinal cord. The fibres pass through to 
the sympathetic ganglia in the inferior mesenteric and superior 
hypogastric plexus. The superior hypogastric plexus is situated at the 
level of the fifth lumbar vertebral body anterior to the aortic 
bifurcation. From here the inferior hypogastric nerves which are the 
major conduits of sympathetic innervation into the pelvis pass down 
into the inferior hypogastric plexus (pelvic plexus) (40). They are 
joined here by the pelvic nerves carrying fibres from the 
parasympathetic system. The pelvic plexus lies near the seminal 
vesicle(41) and several vessels pierce through the plexus on their 
way to the pelvic viscera (Figure 1.2). The pelvic nerves supply major 
excitatory stimulus to the vas deferens and seminal vesicle(42). 
The parasympathetic nervous system contributes albeit to a much 
lesser extent. The preganglionic cell bodies, like the sympathetic 
nervous system, originate from the intermediolateral part of the spinal 
cord from 2nd to 4th sacral nerves. The fibres pass via the pelvic 
plexus and nerves to the pelvic organs(40).  
 
 
 30 
 
 
 
Figure 1.2: Schematic diagram of pelvic (cavernosal) and pudendal 
(dorsal) nerves supplying male genital organs (reproduced from 
Carson  1999)(43) 
 
 31 
1.2.4 Somatic Nervous System 
 
The somatic innervation for ejaculatory function is derived from the 
pudendal nerve. It is formed by the anterior primary rami of the 
second, third and fourth sacral nerves. The cell bodies for the motor 
fibres in the pudendal nerve lie in Onuf’s nucleus. It is situated in the 
ventrolateral part of the anterior horn of the sacral segments. It 
crosses the sacrospinous ligament and passes with pudendal 
vessels in the pudendal canal. Here it gives off the dorsal nerve of 
the penis, the inferior rectal nerve and continues as the perineal 
nerve. The dorsal nerve supplies the corpus cavernosum and the 
glans. The perineal nerve supplies muscular branches to the 
sphincter urethra, the bulbospongiosus, the corpus spongiosus and 
the ischiocavernosus. It also supplies the posterior scrotum(44). 
 
1.2.5 Neuro-physiology of ejaculation 
 
Ejaculation has two phases: emission and true ejaculation. The 
process of deposition of seminal fluid in the posterior urethra is 
known as emission. Adequate function of the vas deferens, seminal 
vesicles, prostate and bladder neck is required for emission. This is 
initiated by hypogastric nerves via thoracolumbar outflow.  There is 
contraction of ampulla of vas deferens, seminal vesicles and the 
prostate to propel the emission fluid to the posterior urethra. The 
bladder neck contracts and the external sphincter relaxes at this 
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time. The innervation of all these structures is primarily 
sympathetic(40).  
 
Ejaculation is the second phase in which the fluid is propelled down 
the urethra towards the external meatus. The rhythmic contractions 
of the bulbocavernosus and the ischiocavernosus are mediated by 
the somatic nerve (pudendal). There is also contraction of the 
periurethral and sphincter muscles(40). 
 
These processes require coordinated autonomic and somatic activity. 
There appears to be a co-ordination centre for ejaculation from T12 
to L1 segments(45). This synchronises the closure of the bladder 
neck and initiates contractions in the ductus deferens. It leads to the 
delivery of semen into the urethra. At this time the perineal striated 
muscles contract rhythmically resulting in expulsion of semen(46). 
 
1.3 Characteristics of Normal Ejaculate 
 
1.3.1 Semen analysis 
 
The normal ejaculate is a combination of spermatozoa suspended in 
secretions of the accessory glands. This results in a viscous fluid. 
The semen is analysed for total volume, pH, sperm motility, forward 
progression, morphology and count. The landmark paper by 
MacLeod and Gold in 1951(47) established a minimum sperm count 
of 20 million per cc as a threshold for fertility. The accepted reference 
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range for semen analysis according to the WHO criteria from 1999 
was used as shown in Appendix I(22). It is to be noted that the 
reference values were reached with some difficulty amongst experts. 
The relationship of semen quality to fertility is quite complicated, not 
the least in that it involves the female factor. This can result in men 
with “abnormal” semen still being fertile whilst men with “normal” 
semen being sub or infertile. Hence, the use of term reference values 
instead of normal values by the WHO manual. 
 
1.3.2 Prostatic & Seminal fluid 
 
The normal prostatic secretion contains zinc, citric acid and acid 
phosphatase The reference range of zinc is 2.4 micro mol per 
ejaculate(48). Fructose gives an estimation of the secretory function 
of the seminal vesicles. The reference value of fructose is 13 micro 
mol per ejaculate(49). 
  
1.4 Patho-physiology of Ejaculatory Failure in SCI patients 
 
1.4.1 Neuro-anatomy 
 
The disruption of corticospinal input following SCI, direct injury to the 
sympathetic chain or lack of sensory input can all result in lack of 
emission. If the disruption is not severe then the bladder neck will not 
close and ejaculation will be in a retrograde fashion. The probability 
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of ejaculation increases with descending levels of injury and 
incompleteness. Hence, about 70% of patients with incomplete lower 
motor neuron injury may ejaculate. On the other hand only about  5% 
of patients with complete upper motor neuron injury can ejaculate(12) 
Recurrent urinary tract infections (UTI) can lead to prostatitis and 
epididymitis in SCI patients. The exact incidence is not known but 
sub-clinical episodes are even more common. These can lead to the 
blockage of ejaculatory ducts and might cause testicular atrophy(50).  
 
1.4.2 Neuro-physiology 
 
There seems to be a disturbance of the pituitary-gonadal axis lasting 
a few months after major spinal cord trauma(51). The hormonal 
levels generally normalise by the end of one year. Hence, sperm 
collection should be deferred for at least 6 months following SCI. 
There can be significant testicular abnormalities at this stage, 
including hypospermatogenesis, tubular atrophy, fibrosis and 
maturation arrest(52;53). There is no correlation of these findings 
with either the level or completeness of SCI. The mechanism is not 
exactly known but it is suggested that interference with sympathetic 
innervation of the epididymis, vas and seminal vesicles leads to a 
failure of co-ordinated action leading to a failure of sperm 
conduction(54;55).  
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1.5 Literature Review 
 
There has been a tremendous improvement in the quality of care 
following SCI. However, infertility remains a major concern. The 
majority of SCI occur in men who are in their reproductive years. 
Even if the patient is not planning to start a family the loss of ability to 
procreate is difficult to accept and can lead to social and 
psychological problems.  
 
1.5.1 Characteristics of Ejaculate following SCI 
 
It has been shown that about 7.5% of men with a SCI have a sperm 
concentration greater than 20 million per ml with the remainder 
having abnormal semen parameters(23). The patients with cervical 
and thoracic level injuries have better sperm motility than those with 
lumbar lesions.  The sperm motility is superior with incomplete than 
with complete injuries(18). 
 
There are differences in the seminal fluid of SCI men as compared to 
able bodied men. The levels of fructose, albumin, glutamic 
oxaloacetic transaminase and alkaline phosphatase are significantly 
low whilst chloride levels are significantly higher(56). 
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1.5.2 Ejaculatory dysfunction in SCI patients  
 
Ejaculatory dysfunction along with poor sperm quality is a major 
cause of infertility in SCI men.  Horne (10) reported in 1948 that only 
18% of men with injuries above the sacral cord can ejaculate.  Talbot 
(27) reported an ejaculation rate of less than 10%.  In 1960 Bors (12) 
reported in the biggest study thus far on the evaluation of ejaculate 
following spinal cord injury.  He reported an ejaculation rate of only 
5% for patients with complete upper motor neuron lesion that 
increased to 32% if the lesion was incomplete.  Conversely 
incomplete patients with lower motor neuron lesions reported an 
ejaculation rate of 70% while 18% with complete lower motor neuron 
lesions could ejaculate.  Brindley(14) suggested that an important 
prognostic factor for ejaculation with a vibrator is the presence of 
bulbo-cavernous (BCR) and hip reflex (HR). He suggested that 75% 
of men with an intact HR will ejaculate. The HR is elicited by 
scratching the soles of the feet. This evaluates the integrity of the 
spinal cord between L2 and S2 segments that are needed for 
ejaculation (57). Szaza and Carpenter in 1989 (58) noted that the 
absence of BCR predicts a failure to ejaculate with VE in most men 
with SCI. This observation by two investigators signifies the 
complexity of problems in this patient group. It appears that the 
ejaculatory dysfunction in SCI men is a complex phenomenon relying 
on a variety of factors rather than a single factor abnormality.   
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1.5.3 Medications for ejaculatory dysfunction in SCI patients 
 
Various investigators have demonstrated that it is difficult to obtain 
ejaculation in SCI men. Hence, attempts have been made to assist 
this process. Naturally, the initial endeavours were to facilitate 
ejaculation with medications. Guttman in 1947(59) reported retrieval 
of sperms in SCI men following intrathecal instillation of neostigmine. 
This led to ejaculation in men with SCI.  He reported a success rate 
of around 60% in 70 patients with supra sacral SCI(60).  However 
this was not popularised due to bothersome side effects.  There were 
severe incidents of autonomic dysreflexia with 1 reported death.  
Later on an ejaculate was obtained by subcutaneous injection of 
physostigmine followed by masturbation(61).  However this was also 
not popularised due to side effects.   
 
1.5.4 Invasive techniques for sperm retrieval in SCI patients 
 
A variety of techniques have been tried to induce ejaculation in SCI 
men. 
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1.5.4.1 Direct aspiration from vas deferens 
 
Spermatozoa can be obtained by direct aspiration from the testis or 
the vas deferens(62-66). A variety of methods have been employed 
to this end. These include testicular sperm aspiration or extraction, 
microsurgical or percutaneous epididymal sperm aspiration or 
aspiration from the vas deferens. Although successful pregnancies 
have been reported these are invasive techniques and not 
particularly liked by the patients. However, it has been demonstrated 
in more than 100 fertility centres, that a quarter will not offer VE or 
EEJ as a first line method of sperm retrieval, instead the patient will 
undergo surgical sperm retrieval(24).The reason for not offering VE 
or EEJ in these centres was lack of training and education. Surgical 
methods typically result in a low quality ejaculate committing the SCI 
men to assisted methods of fertilization like in-vitro fertilization (IVF) 
and intracytoplasmic sperm insemination (ICSI) and the resulting 
high costs. Hence, it has been recommended that non-invasive 
techniques should be tried first(19) and if these are unsuccessful 
then the patient should undergo a surgical method of sperm retrieval.  
 
1.5.4.2 Electro-ejaculation for ejaculatory failure  
 
The first case of EEJ being used to obtaining human semen was 
reported by Horne(10) in 1948.  He was able to retrieve semen in 8 
of 15 patients without any complications.  This was, later on, 
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popularised by Brindley(67). He reported an antegrade ejaculation 
rate of 43% (total 84 patients) and a retrograde ejaculation rate of 
16%.  This procedure has been refined overtime by Seager and the 
success rate of obtaining a sample with EEJ for any level of injury is 
well above 90%(45;68-72). This is performed with an electrical probe 
in the rectum. An electrical current is applied to deliver direct 
stimulation of current to the pelvic nerves via the prostate and 
seminal vesicle (73). The ejaculate is more an emission than a true 
ejaculation(67;74). This has to be performed in a hospital by a 
physician with continuous monitoring of blood pressure as it can 
induce autonomic dysreflexia(45;67).  The main advantage is that 
EEJ can be used for any level of SCI but patients with an incomplete 
injury require anaesthesia. The bladder is emptied before the 
procedure and a sperm friendly medium like Ham’s composition is 
instilled into the bladder to prepare for retrograde ejaculation(20;75). 
The current is applied in 2-5 volts increments and then switched off. 
It has been shown that the antegrade flow of semen occurs when the 
current is switched off (76). A proctoscopy is performed before and 
after the procedure to rule out any injury to the rectal mucosa. 
Seager Model 14 Electroejaculator (Dalzell USA Medical Systems, 
Marshall, VA) is the only Food and Drug Administration (FDA) 
approved device for performing EEJ (figure 1.3) in humans(7). 
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Figure 1.3: Seager electroejaculator device with rectal probe 
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Sperm motility declines rapidly after mixing with urine (77). This can 
be offset somewhat by instilling Ham’s solution into the bladder 
before starting the procedure. It has been suggested that EEJ is 
potentially damaging to semen as compared to VE(14).  
 
1.5.4.3 Vibro-ejaculation for ejaculatory failure  
 
VE was first reported by Sobrero(78) in 1965.  Again, Brindley (79) is 
largely accredited for popularising this technique.  He was able to 
ejaculate about 60% of the 81 men with paraplegia of greater than 6 
months duration.  The incidence of retrograde ejaculation much lower 
than EEJ (20). The main advantage of VE is that it can be performed 
in the home environment. T 
his allows for a home insemination programme to be instituted, which 
not only reduces the cost and side-effects of the procedure, but is 
also more personal. Furthermore, a home insemination programme 
is closer to natural conception. VE is a safe and cost effective 
method and yields the highest number of antegrade motile sperms. 
Hence, it is recommended that it should be employed as the primary 
method for sperm retrieval in SCI men(75;80). Over the years a 
variety of devices have been used to perform VE but currently the 
only instrument approved by the FDA is the Ferticare® personal 
vibrator (Multicept, Albertslund, Denmark) figure 1.4(7). 
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   Figure 1.4: Ferticare® penile vibrator 
 
 
 
 
Figure 1.4: Ferticare® personal vibrator 
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The aim of VE is to activate the ejaculatory arc at the thoracolumbar 
level(73).  This requires an intact dorsal penile nerve; a sensory 
branch of the pudendal nerve. The fibres terminate in the sacral 
segments 2-4(81;82). SCI men with an injury above T10 can 
ejaculate in up to 88% of cases, whilst SCI men with injury below T11 
report a success rate of only 15%(24). Hence, it is accepted that VE 
should be tried for patients with a spinal cord lesion above T10. 
The stimulation is applied to the glans and afferent impulses pass via 
the dorsal penile nerve.  An antegrade ejaculation is obtained in a 
projectile manner almost similar to normal ejaculation(73).  The 
average time required for obtaining an ejaculate by this technique is 
between 10 seconds to 45 minutes(17;58;79). If there is no response 
in 2-3 minutes then the stimulation is stopped. After a gap of 1-2 
minutes the stimulation is performed again. The process is repeated 
until either the ejaculate is obtained or the stimulation has been 
performed for up to 10 minutes(83). Generally, almost 90% of the 
SCI men who will ejaculate with VE do so within 2 minutes of starting 
the stimulation. Additional methods have been employed to facilitate 
ejaculation in unsuccessful cases. An increase in the success rate 
has been reported with the application of 2 vibrators, one above and 
the other underneath the glans(84). This can be employed at the first 
visit or after multiple unsuccessful attempts with one vibrator. During 
ejaculation there might be contraction of the abdominal muscles and 
leg spasms may be seen.  A very important consideration for 
success with VE, as described above is an intact reflex arc at the 
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thoracolumbar level (14;20;85). However, the success rate with VE is 
variable and the reported range is between 19-91% (15;17;79;86-88). 
The highest rate of ejaculation was seen with an amplitude of 2.5mm 
and a frequency of 100HZ (89).  The completeness of injury is not a 
definite prognostic factor for obtaining semen by VE(14;58). The 
most common side effect with VE is skin abrasion which does not 
require any specific treatment. The patients with an injury above the 
level of T6 can develop autonomic dysreflexia(90). Nifedipine can be 
given to the susceptible patients. However, there is no need to 
prescribe this medication prophylactically. It has been shown that 
sperm motility is better with VE as compared with EEJ(19).  
 
1.5.4.4 Prostatic massage for ejaculatory failure  
 
The sperms are stored in the ampulla of vas deferens and can be 
sequestered in the seminal vesicle(91). Prostate massage can be 
employed to obtain sperms by performing a rectal examination and 
mechanically pressing on the prostate and seminal vesicle. This 
indeed has been reported to lead to successful pregnancies(92;93). 
However, the sperms quality is very low. This can be employed in 
men who have failed VE but cannot undergo EEJ for any reason. 
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1.5.5 Distinctive semen profile in SCI men 
 
The SCI men have a distinctive semen profile. This is characterised 
by abnormal semen parameters including a very poor motility and 
morphology(94). The quality of sperms has consistently been shown 
to be poor in all series examining semen in SCI men(13;19;95;96). 
The testes also demonstrate histological abnormalities in a number 
of studies(10;11;52;97).There is a lower mean spermatid count with a 
higher Sertoli cell count per seminiferous tubule. Also, there can be a 
higher Sertoli cell to spermatid ratio as compared to controls (98).  
However, it is difficult to objectively compare these studies as almost 
all have used different methods of analysis(99).  
 
1.5.5.1 Semen characteristics during the acute phase following 
SCI  
 
There is a lack of information regarding semen characteristics during 
the acute phase after SCI. This may relate to the medical and 
psychological trauma of SCI and unwillingness of investigators to 
introduce the subject of fertility during this phase (100).  There is a 
single study in humans in the literature(101) which has addressed 
the acute effects of SCI on sperm characteristics.  In the study EEJ 
was performed in 7 men starting from the 2nd day following a SCI.  
There was no abnormality in the sperm characteristics up to the 16th 
day.  Thereafter sperm motility deteriorated rapidly. This study has 
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never been replicated in humans. However, Ohl and colleagues 
(100) studied the acute effects of SCI on the semen quality and 
spermatogenesis in a canine model. Seven dogs underwent surgical 
T7 SCI. There were 6 controls. EEJ was performed at baseline and 
then twice weekly for 3 weeks. They demonstrated that sperm 
motility and spermatogenesis decreased significantly but not before 3 
weeks in SCI dogs. The similarity of motility changes between the 
two studies (100;101) demonstrates that the canine model can mimic 
the human situation. There have been other attempts at evaluating 
the acute changes in spermatogenesis (102) and epididymal sperm 
motility (103). However, these later investigations lacked the ability to 
evaluate the serial changes in spermatogenesis and ejaculated 
semen quality (100).  There are many other issues to consider in the 
immediate period following SCI. The surgical stabilization of the 
spine with the management of associated injuries takes precedence 
over evaluation of fertility potential. Most of the patients are also not 
in the right frame of mind to undergo EEJ immediately after SCI. 
 
1.5.5.2 Semen characteristics during the chronic phase 
following SCI 
 
The patho-physiology and the mechanisms which lead to the 
deterioration of sperms following SCI are largely unknown. In most 
series evaluating the semen from SCI patients, the ejaculate was 
obtained by vibration, chemical or electrical stimulation. The sperm 
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count was less than 20 million per ml in more than 85% of the cases 
and the motility was less than 40% in almost all the 
cases(45;67;104;105). The reported motility varied, with some 
studies reporting 0.5% whilst others reported a motility of more than 
40% (45;67;104;105). It was also demonstrated that the motility was 
better with incomplete injuries and in SCI men who had cervical and 
thoracic lesions as compared to complete injuries and lumbar lesions 
(18). It has therefore been suggested that a host of factors in 
combination lead to the deterioration of sperm quality(99).   
The various suggested causes of poor sperm quality following a SCI 
include: 
1- Stasis of prosthetic fluid(106;107) 
2- Testicular hyperthermia(108) 
3- Recurrent urinary tract infections(109;110) 
4- Type of bladder management(18) 
5- Abnormal testicular histology(97) 
6- Changes in pituitary testicular axis(68;111;112)  
7- Possible antisperm antibodies(111;113) 
8- Long term use of various medications(12;114)  
A number of investigators have suggested that the stasis of semen in 
the ejaculatory ducts leads to a deterioration in sperm motility 
(106;107).  Brindley has shown a progressive increase in sperm 
motility with repeated EEJ(14). Francois et al have demonstrated an 
increase in sperm motility of a man with repeated ejaculations from 
0% to 30% (107).  
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Some investigators have reported that frequent VE for 3-6 months 
will improve the quality of sperms following SCI(15;17). Interestingly, 
Ohl et al(18) reported no improvement in semen quality in patients 
who had intermittent spontaneous ejaculations but showed 
improvement in semen quality in SCI patients who underwent 
repeated electo-ejaculation 2-4 times under their care. On the other 
hand, Sonksen in 1999(115) reported no beneficial effects of 
repeated ejaculations on the quality of sperms. He performed VE 
weekly for one year in a series of 18 patients and did not find any 
significant improvement in any of the semen parameters.  
 
Increased scrotal temperature has been implicated as a factor for 
decreased motility although this has not been proven.  Brindley(108) 
demonstrated a significant correlation between high scrotal 
temperature with lack of motile spermatozoa in paraplegics sitting in 
wheelchairs. However, other investigators have found no correlation 
between high scrotal temperature and semen characteristics in SCI 
men and non-injured subjects as controls(116;117). 
 
UTI are not uncommon in SCI men(118). They are thought to 
adversely affect fertility.  It has been noted that 60% to 70% of the 
patients with SCI can have bacteriuria on routine examination of the 
urine(119). Recurrent UTI can lead to epididymo-orchitis resulting in 
obstruction of the ducts(120). It has been shown that patients who 
have urinary reflux on video-urodynamics might have chronic 
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infections leading to deterioration of sperm quality(18). A lower 
sperm count and motility has been demonstrated in men with chronic 
prostatic infection(109). The urine itself is thought to be extremely 
detrimental to sperm motility(77;121).  It has been suggested that 
sperm motility is halved after mixing with urine for only 5 minutes(77). 
On the other hand no significant difference was seen in ejaculates 
from SCI men with infected urine as compared to non-infected 
urine(122).    
 
Poor sperm quality is also thought to be related to the atrophy of 
semineferous tubules(123). There appears to be a higher sertoli cell 
count per seminiferous tubule. However, as with most theories 
investigators have found both normal and abnormal testicular 
histology in SCI men with no significant correlation to the level of 
injury, the duration of SCI or to the number of urinary tract 
infections(52;68;97).    
 
It has also been suggested that hormonal changes occur following 
SCI and the level of FSH and LH and the production of testosterone 
is altered(111). Initial studies showed that the levels of FSH and LH 
were elevated but testosterone levels were normal. Most of the 
studies have shown conflicting results with hormonal levels both 
above and below normal values(124;125). It has been suggested that 
the reason for the inconsistency can be the pulsatile nature of the 
 50 
release of the gonadotrophins and it may be difficult to pick up the 
subtle changes in the hormonal levels with any consistency(126).   
 
Another theory is the production of antisperm antibodies following 
SCI(113). Two conditions are thought to be associated with 
antisperm antibody production. One is the obstruction of ejaculatory 
ducts secondary to epididymitis(68), but the reason for the 
development of antibodies is not known(126;127). The second 
possibility is recurrent UTIs leading to a prostatic immune 
reaction(128). Again, various investigators have documented both 
the presence and absence of antisperm antibodies in SCI men(129-
131). No significant correlation has been established between 
antisperm antibodies and sperm quality but it is thought that 
antibodies in the seminal plasma might exert a deleterious effect on 
sperm quality(132). It has been demonstrated that up to 70% of the 
men develop antisperm antibodies after undergoing vasectomy(126) 
suggesting that obstruction might lead to development of antisperm 
antibodies that play some role in causing a poor sperm quality in SCI 
men. 
 
The method of bladder emptying is also thought to play some part in 
the deterioration of sperm quality. It has been shown that SCI men 
who empty the bladder with SIC or have a sphincterotomy have 
better sperm motility (27%) than those emptying the bladder by reflex 
voiding or with an indwelling catheter (5%)(18). However, even those 
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voiding spontaneously did not have normal sperm motility indicating 
that the method of bladder drainage cannot be solely responsible for 
the deterioration of sperm characteristics after SCI. Rutkowski(133) 
demonstrated that SIC is superior to other methods of bladder 
drainage in terms of delivering motile sperms after both VE and EEJ 
in SCI men. 
 
Men with SCI are not infrequently on a variety of medications. A 
number of them will have been taking various medications for 10 
years or more. There are no studies demonstrating the safety or 
otherwise of medications on sperm quality(19). Nitrofurantion causes 
spermatogenic arrest in rats, which is reversible(134). Similarly 
prostaglandins, used as pain killers, can lead to infertility in 
men(135). Alpha blockers can lead to bladder neck relaxation and 
are also thought to affect the smooth muscle contractility of the vas 
deferens(136). We do not know the long term effects on 
spermatogenesis of some commonly used medications in SCI men 
like trimethoprim, quinolones and diazepam(137). Nifedipine is given 
for prevention of autonomic dysreflexia. In a study, this has been 
shown to inhibit the contraction of isolated human seminal vesicle 
tissue (138). There are no other studies specifically looking at the 
effect of Nifedipine on human ejaculatory tissues. However, in rats it 
has not been shown to delay ejaculation in vitro (139). Hence, the 
exact role of Nifedipine in relation to human ejaculatory function is 
not known. 
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The method of obtaining ejaculate has also been studied as a 
potential cause of poor sperm motility in SCI men. It was initially 
thought that the there was no difference in the quality of semen 
regardless of the technique of sperm retrieval (19). However, later 
studies demonstrated that motility is better with VE (24%) as 
compared to EEJ (12%)(20;21) but it is still well below 50% of what is 
considered normal by WHO criteria. The biochemical composition of 
EEJ semen of SCI men differs from that of the masturbated semen of 
normal men (56;140). 
 
Leukocytes are seen in almost all semen samples from SCI 
men(141;142). They have been associated with male infertility in able 
bodied men but the treatment of infections in SCI men has not been 
shown to improve the sperm motility in this group(122). Interestingly, 
the SCI men have demonstrated a large number of activated T 
lymphocytes which secrete cytotoxic cytokines(143). Some studies 
have shown improved sperm motility once these cytokines were 
neutralised(144;145). However, it is not clear if leukocytospermia 
plays a significant role in the deterioration of sperm quality in SCI 
men.  
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1.5.5.3 Role of seminal fluid in poor quality semen following SCI 
 
There is abnormal prostate and seminal vesicle function in men with 
SCI(146-148).  Recent investigations have suggested that seminal 
plasma may play a crucial role in causing deterioration of sperm 
motility and forward progression. As a result of SCI there can be 
denervation of accessory glands (prostate and seminal vesicle) that 
might contribute to an abnormal semen quality(7). The semen of SCI 
men is brown in colour in more than 25% of the cases. This was 
previously thought to be related to stasis due to infrequent 
ejaculations. However, microscopic examination has revealed that 
the discoloration of semen might be related to a dysfunction of the 
seminal vesicle. The SCI men with brown ejaculate have a lower 
semen volume and a thinner consistency compared to men who do 
not have a brown semen(149).  It has been shown that seminal 
plasma obtained with the ejaculate from SCI men inhibits the motility 
of normal sperms. Conversely the sperms from SCI men improve 
their motility if they are mixed with seminal plasma from able bodied 
individuals(150).  It has also been shown that the sperms of men with 
SCI demonstrate significantly better sperm motility and viability when 
aspirated from the vas deferens as compared to sperms obtained 
with VE or EEJ(151). In 12 SCI men the mean sperm motility 
aspirated from the vas deferens was 54.4% while in the healthy non 
SCI age matched controls it was 77.5%. The mean sperm motility in 
the ejaculated specimen of SCI men decreased to 14.1% while there 
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was no change in the non SCI age matched controls. A large number 
of poor quality sperms were found in the seminal vesicle of SCI 
men(91). These are the sperms comprising a major portion of the 
ejaculate with VE and EEJ. Another study demonstrated lower levels 
of fructose and albumin in the semen of SCI men pointing to the 
accessory gland being a factor in causing the deterioration of sperms 
after SCI(56). There is also prostate gland dysfunction in SCI men. 
The PSA is lower in the semen(147;152) but higher in the 
serum(147) of SCI men when compared with age matched controls. 
Interestingly, the prostate of SCI men are smaller than age matched 
controls(153;154). The significance of this is unknown. A number of 
studies have demonstrated abnormal concentrations of various 
substances in the seminal plasma of SCI men as compared to able 
bodied controls. The concentration of platelet activating factor 
acetylhydrolase(155), reactive oxygen(156), and somatostatin(157) is 
higher in SCI men than controls. Whilst, the concentrations of 
fructose, albumin and alkaline phosphatase(56) are lower in SCI men 
than in controls. Recently, in a very elegant experiment Maher et al  
employed nuclear magnetic resonance spectroscopy to analyze 
seminal fluid metabolite profiles in 10 men with and 8 men without 
SCI above T10 (158). They demonstrated that uridine is likely to be 
an essential precursor to metabolites required for capacitation and is 
a potential marker for the prognosis of post-SCI functional fertility 
recovery. A new term "seminal oligouridinosis" was coined to 
describe this newly identified condition. The above data provides 
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evidence that seminal plasma is probably a major contributing factor 
to the deterioration of sperms following SCI, however the exact 
correlation between seminal fluids and abnormal sperm 
characteristics in SCI men remains to be determined.  
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1.5.6. SCI men achieving successful fatherhood 
 
A number of investigators have reported that SCI men have been 
successful in achieving fatherhood. This has been reported with both 
home insemination programme and assisted fertility techniques. 
 
1.5.6.1 Home insemination programme with intra-vaginal 
insemination 
 
This is a viable option for SCI men who can either ejaculate 
spontaneously or with the help of VE. The patients and their partners 
are taught the technique of collecting semen in a non-spermicidal 
container and vaginal delivery via a 10 ml syringe(57). Brindley in 
1984(14) reported seven pregnancies with the birth of 5 healthy 
babies after VE and vaginal self insemination. Several others have 
also reported successful pregnancies with VE and self insemination 
programmes(28;29;72;159). Most utilised multiple ovulation cycles 
and the overall pregnancy rate per couple was 25 – 61%. In a recent 
trial in 3 countries at 4 large centres 43% of the partners of SCI men 
achieved pregnancies with intra-vaginal insemination(7).  
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1.5.6.2 Insemination programme with intrauterine insemination 
 
Intrauterine insemination is recommended if the intravaginal 
technique has failed. Ohl et al(160) reported a per cycle pregnancy 
rate of 8.6%. They recommended that if the total sperm count was 
less than 4 million motile sperm then the patient should proceed 
directly to IVF as the chance of pregnancy per cycle was only 1.1%. 
On the other hand if the motile sperm count was more then 40 million 
then the success rate per cycle increased to 17.6%.  
 
1.5.6.3 Assisted techniques for conception  
 
Success has been reported with assisted reproductive techniques 
including IVF and ICSI utilising sperms obtained by VE or EEJ 
(11;28;29;30;72;159). The success rate in SCI men with assisted 
techniques is 25% per cycle(11;30;72;159;161) which is comparable 
to pregnancy rates achieved with these techniques in able bodied 
men(162). Surgical sperm retrieval has also been used to obtain 
sperm in SCI men as a first line treatment without trying VE or 
EEJ(24). The reason cited is the lack of training of physicians in 
these techniques due to the small number of patients with SCI. 
However, it is the physicians responsibility to inform the patient of all 
the options available even if he or she cannot offer all the 
treatments(163) and to explain why a particular option is futile(164). 
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1.5.7 Techniques to improve semen quality in SCI men 
  
Various studies have been carried out to improve the quality of 
sperms in men with SCI. However, the only technique employed to 
improve the quality of sperms has been to perform repeated 
ejaculations either with VE or EEJ. Some studies have substantiated 
this hypothesis(15;17;107) while others have found no appreciable 
improvement in sperm characteristics with repeated 
ejaculations(45;115;165). However, none of these studies were 
randomized with a control group. Interestingly, it has been shown 
that SCI men might stop ejaculating with repeated ejaculation after 
initial success with VE(15). The cause of this phenomenon is not yet 
ascertained. 
Siosteen and Beretta have suggested that the quality of semen can 
improve after repeated VE(15;17).  30 men vibrated on a weekly 
basis at home for 3 to 6 months.  They compared the first ejaculate 
with that produced after 3 to 6 months of repeated ejaculation.  Both 
the authors reported that the sperm quality improved after repeated 
VE.  There was improvement in motility and concentration but 
importantly there was a decrease in abnormal sperm morphology 
after a prolonged use of a vibrator. Siosteen found that the total 
count of motile sperms and the level of fructose also increased.  He 
suggested improved function of the seminal vesicles and the 
prostate.  Additionally, the sperm penetration capacity reached 
almost normal levels after repeated ejaculation. Mallidis(166) 
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demonstrated an improvement in sperm motility and viability with 
repeated EEJ for 4 consecutive days. On the other hand Sonksen 
(115) performed repeated VE for 19 SCI men over 1 year and did not 
find any significant improvement in any of the semen parameters. 
Similarly, Das et al performed 3 successive EEJ in 16 patients at 2 -4 
week interval and did not find any improvement in semen 
parameters(167). Hence, there is no conclusive evidence either way 
that the quality of sperms can be improved objectively. Additionally, 
Sarkarati(45) demonstrated that the quality of the semen is not good 
during the first 6 months. Thereafter there is no appreciable decline 
in sperm quality(168). 
 
1.5.8 Deficiencies in the literature 
 
It can be derived from the above data that no single factor is 
responsible for poor quality sperms following SCI. It is the 
combination of factors described above that collectively lead to the 
deterioration of semen quality post SCI. However, it is surprising that 
no controlled studies in humans have been performed to 
demonstrate the exact cause of poor semen quality. There have few 
studies in humans on this subject but they have mostly looked into 
stasis as a cause of poor sperm quality(106;107). None of these 
studies were conducted as a randomised controlled trial with a 
control group. The only controlled study performed to evaluate the 
acute changes in semen quality was undertaken by Ohl and 
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colleagues in a canine model (100). They demonstrated a significant 
decrease in sperm motility but not before 3 weeks in SCI dogs. 
Although, this study closely mimics the human situation after SCI no 
long-term studies are available to test the progression of these 
changes into the chronic stages of SCI.   There have been some 
studies evaluating the role of seminal plasma in poor quality semen 
but again these have mostly been observational studies(56;150;151). 
Although all investigators agree that the semen quality is poor and 
the cause is multifactorial no suggestions have been put forward to 
identify the most critical factors leading to the deterioration of sperms 
in SCI men. Hence, further studies are required to focus on 
ejaculatory dysfunction, seminal vesicle and vas deferens function 
and thorough evaluation of seminal plasma. This might shed more 
light on the causation of poor semen quality in SCI men.  
 
1.6 Aim of this study 
 
There is a gap in the literature as to why the SCI men have poor 
quality semen. Several theories have been put forward as discussed 
earlier, but no definite answers have been found. Certainly, it is 
agreed there is no single factor responsible for all the changes 
leading to poor sperm quality in SCI men. Previous studies have 
attempted to determine whether one of the suggested factors; 
repeated VE can improve the quality of sperms in SCI men. The 
results of these studies so far have been contradictory with some 
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demonstrating that repeated ejaculations can improve the sperm 
quality, whilst others indicative of that this particular intervention does 
not make any appreciable difference to the quality of sperms in SCI 
men. Importantly, no human study was a randomised control trial.  
 
As there is no consensus as to the exact cause for poor quality 
semen, no effective treatment can be suggested to improve the 
sperm quality in a SCI man.  
 
Hence, a randomised controlled study was designed to study the 
effect of repeated ejaculation using VE in patients with a SCI. The 
aim was to evaluate if this particular factor can lead to an 
improvement of semen parameters in SCI men. 
 
1.6.1 Null Hypothesis 
 
To evaluate if repeated ejaculations improve the quality of sperms in 
SCI men the experiment was designed to test the null hypothesis. 
This will state that any intervention like repeated ejaculations will 
have no significant impact on the quality of sperms in SCI men. 
 
1.7 Summary 
 
The exact cause of the deterioration of the quality of sperms 
following SCI is not known. A host of factors have been described in 
 62 
the pathophysiology of poor sperm quality following SCI. However, 
there is no conclusive evidence that there is a single factor causing 
the deterioration of sperms in SCI men. With the establishment of 
IVF and ICSI techniques the emphasis is now on obtaining a single 
or few sperms and utilising these assisted fertility techniques to 
achieve pregnancy. This is a reasonable approach with a good 
chance of success. However, one has to keep in mind that these 
techniques require a considerable amount of time, and more 
importantly, money. Hence, if a technique could be demonstrated 
that would improve the quality of sperms in a non-invasive manner 
then the patients could try to improve the quality of sperms in the 
home environment. If this was successful, a home insemination 
programme could be instituted. This would not only be cheap but 
would also be close to the natural method of conception. This would 
enhance the self-esteem of SCI men and help in their re-integration 
within the community. In the event that this technique failed, then 
assisted fertility techniques could be tried to achieve a successful 
pregnancy. 
 
The best possible chance of ensuring a successful fertility 
programme is through a Multi-Disciplinary Team.  This should include 
rehabilitation physicians, urologists, gynaecologists, psychologists, 
nurse co-ordinators and a reproductive endocrinologist. 
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2 MATERIALS AND METHODS 
 
2.1 Overview of the project setting 
 
The study was designed and performed at the London Spinal Cord 
Injury Centre, Royal National Orthopaedic Hospital, Stanmore. A 
dedicated room was set up at the premises for the performance of 
VE. The equipment for the evaluation of semen was placed in one 
corner of the laboratory. The invitation for participation in the study 
was extended by all members of the unit including urologists, clinical 
scientists, rehabilitation physicians and specialist nurses both during 
in-patient and out-patient consultations. Additionally, it was publicised 
through the SCI charity (ASPIRE). All invited subjects were under the 
care of the unit for spinal rehabilitation.   
 
2.2 Regulatory requirements 
 
The local research and ethics committee approved this study. The 
trial was carried out in accordance with the "Recommendations 
guiding physicians in biomedical research involving human subjects - 
Declaration of Helsinki(169). 
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2.3 Study design 
 
The subjects who successfully ejaculated antegradely in the clinic 
with help of the Ferticare® personal vibrator without any apparent 
contra-indications were randomised into either the study or control 
groups. The study group was required to VE weekly and semen 
analysis was performed at baseline and then on a monthly basis for a 
total of 3 months. The subjects in the control group were ejaculated 
at baseline and then at the end of 3 months. The control group was 
advised to abstain from ejaculation by any method. 
 
2.4 Subject selection 
 
The subjects were invited to the hospital for screening and baseline 
evaluation of the ejaculate.  The inclusion and exclusion criteria are 
given in appendix II. All aspects of the study were discussed with 
them according to the patient information sheet as described in 
appendix III. The subjects were given adequate time to discuss the 
protocol with their partners if they so wished and then were given an 
opportunity to ask questions. They were encouraged to come back at 
a later date if they so wished. Once they understood the 
requirements of the study and were happy to proceed, all subjects 
signed the consent form (appendix IV). A total of 79 subjects agreed 
to participate in the study.   
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2.5 Subjects  
 
The patients with an injury level above T10 were invited to participate 
in this study. Subjects with both complete and incomplete injuries 
were eligible to take part.  The minimum duration since the time of 
injury was set at 6 months in line with previous studies by 
Brindley(14) and Siosteen(15). It was considered to randomise 
patients separately by completeness of injury and with method of 
bladder drainage but it was concluded that it would be almost 
impossible to recruit sufficient numbers of patients for adequate 
statistical analysis of results. 
The mean age of the subjects at injury was 28 years (range 11- 47 
years) and the mean age at procedure was 42 years (range 26 - 63 
years).  The mean duration since injury was 7.7 years (range 0.5 – 
44 years). Of the 79 subjects, 39 had injury at cervical level, 25 
subjects had injury at thoracic levels T1-T7 whilst 15 had an injury 
level between T7-T10.  There were 41 complete and 38 incomplete 
injuries.     
45 subjects were performing SIC for bladder management.  17 
subjects had a SPC, 8 were voiding on urge, 8 were reflex voiding 
whilst 1 patient had a sacral anterior root stimulator (SARS). 
An attempt was made to evaluate if BCR and HR could predict a 
successful outcome of the procedure. However, on analysis of full 
data it was discovered later on that clear documentation for these 
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was only performed in 33 subjects by both the observers. Hence, this 
could not be included in final analysis. 
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2.6 Materials and equipment 
 
The following materials were required to perform the project 
successfully. 
 
2.6.1 Microscope 
 
A Zeiss Compound microscope was used for evaluation of the 
ejaculate (Figure 2.1). The microscope had magnifications of 10, 20, 
40 and 100 (oil immersion) with an ocular piece of 10X.  For the 
purpose of assessment of motility, forward progression and for sperm 
counting the magnification of 10, 20 or 40 was used.  Sperm 
morphology was analysed with a 100 magnification under oil 
immersion.   
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Figure 2.1: Zeiss microscope 
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2.6.2 Mini-therm stage warmer 
 
A mini-therm stage warmer (Hamilton Thorne Research, Beverly, 
MA, USA) was used to analyse the motility and forward progression 
of sperms at 37° C. The stage was pre-heated to 37° C. The 
temperature was checked with the control slide. When the colour of 
the control slide changed from black to green, it signified the 
achievement of the desired temperature.  The mini-therm stage fits 
easily onto the slide holder of the Zeiss compound microscope. 
There is a slot within the mini-therm stage warmer to accommodate a 
standard slide.  The mini-therm stage warmer was continuously 
heated so as to keep the temperature constantly at 37° C for 
accurate assessment of sperm motility and forward progression at 
body temperature (Figure 2.2). 
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Figure 2.2: Mini-therm stage warmer with control slide 
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2.6.3 Microscope slides and cover slips 
 
Standard pre-cleaned frosted slides were used for performing all 
microscopic evaluations. A 1 inch cover-slip was used on top of the 
slides for the assessment of motility and forward progression.    
 
2.6.4 Pipettes 
 
1- Positive Displacement Pipette: A Positive displacement pipette 
(Eppendorf) was used for accurate assessment of the sperm motility 
(Figure 2.3). It withdraws a fixed volume of semen (10 micro litres). It 
is often used when the fluid being examined is viscous. A disposable 
chamber was used which was discarded after each evaluation.  
 
2- Normal Pipette: A normal pipette (Eppendorf) was used for 
evaluation of the sperm count. It withdraws a pre-determined volume 
of formalin which is added to a fixed volume of semen for fixation of 
sperms to evaluate accurately the count (Figure 2.4). The Eppendorf 
pipettes have plastic connectors which are single use and were 
discarded after single use. 
 
 
3- Plastic Pipettes: Normal single channel plastic pipettes were used 
with adjustable volume setting.  They were used for withdrawing 
semen from the containers. They were discarded after each use.   
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Figure 2.3: Positive displacement pipette 
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      Figure 2.4 : Normal pipette 
 
 
 
 
 75 
2.6.5 pH strips 
 
The pH strips from Bayer® were used for the assessment of the pH. 
 
2.6.6 Plastic bottles 
Open mouthed plastic containers were used for the collection and 
evaluation of semen during the study. They were single use and 
discarded after each study. 
 
2.6.7 Haemocytometer 
 
A haemocytometer with neubauer chamber was used for counting 
sperm (Figure 2.5). It was washed in running water and cleaned with 
alcohol wipes after every use. 
 76 
 
 
 
 
 
 
     Figure 2.5: Haemocytometer 
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2.6.8 Solutions used for assessment of morphology 
 
The following solutions were used for the assessment of morphology: 
1- Ethanol 
2- Distilled water 
3- Haematoxolin 
4- Eosin 
5- Alcohol 
6- Tap water 
The details of the solutions and the preparation of slides are given in 
appendix V. 
 
2.6.9 Ferticare® personal vibrator 
 
The ejaculation was performed using a Ferticare® personal vibrator 
(Multicept, Albertslund, Denmark).  The vibrator had to be charged 
overnight for 16 hours before adequate usage. It had 2 settings, 1 for 
amplitude and the other for frequency. The vibrating disc was on the 
top (Figure 2.6).  The on/off button was on the side. The device had 
to be used with care so as not to overload the system. The subjects 
in the study arm were loaned the vibrator and explained the 
technique of performing ejaculations once a week. 
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       Figure 2.6: Ferticare® personal vibrator 
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2.7 Performance of vibratory stimulus 
 
 
2.7.1 Pre-procedure preparation  
 
 
The baseline ejaculation was performed in the laboratory. It was 
ensured that a blood pressure monitor and an emergency 
resuscitation apparatus were available in the room.  All subjects 
prone to autonomic dysreflexia were given prophylactic Nifedipine 
10mgs.  Otherwise it was ensured that this medication was available 
in the laboratory in the event that the subject developed autonomic 
dysreflexia.   
After discussing the patient information sheet (Appendix III) with the 
subjects and answering all the questions, consent was obtained on 
the form approved by the ethics committee (Appendix IV). The 
subject relevant pre-operative and post-operative history was 
recorded in the data collection sheet (Appendix VI). 
He was then seated comfortably, ensuring that the facility was 
available to elevate the back rest in case of the subject going 
autonomic.  The temperature of the laboratory was set at 25° C. The 
partner, if accompanying was seated in the corner. For the subject 
performing SIC the bladder was emptied with the catheter. In case of 
a SPC the leg bag was emptied.  The condom sheath was removed 
for those on this method of bladder drainage. A careful assessment 
of the glans and penile skin was then made for signs of any abrasion 
or skin lesion. The urine samples were not routinely tested to check 
for infection as those subjects who were complaining of symptoms of 
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a urine infection were not brought for screening unless the infection 
was cleared.   
 
2.7.2 Demonstration of the Ferticare® personal vibrator 
 
 
A Ferticare® penile vibrator (Multicept, Albertslund, Denmark) was 
used to collect the samples. A demonstration of the vibrator was 
performed to familiarise the subject with the equipment, especially to 
acquaint him with the typical noise produced by the vibrator. The 
vibrating disc was also placed against one of his fingers to give the 
subject a feeling of what to expect.  The settings were then explained 
to the subject and the partner. The subject was told to expect 
spasms in the lower part of the abdomen and the upper part of the 
thighs. He was reassured that this was quite normal and that the 
spasms would increase as he was about to ejaculate.  
It was explained to the subject that the initial vibrations would be 
performed for 2 to 3 minutes or until he ejaculates. The settings 
would then be increased and further attempts would be performed. 
This would continue until the procedure was successful, the subject 
requested to stop or he developed any adverse symptoms. A 
maximum number of attempts were not set before the start of the 
project but it was expected that no more than 6 attempts would be 
made in one evaluation. 
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2.7.3 Use of Ferticare® personal vibrator to obtain semen 
sample 
 
The principle investigator stood on the right side of the subject with 
the collector on the left side. The collector held an open mouthed 
plastic container to ensure that the complete sample was collected. 
A blood pressure (BP) monitoring equipment was kept available in 
the procedure room but continuous monitoring of the BP was not 
performed. The initial settings on the vibrator were calibrated to a 
frequency of 100 Hz with an amplitude of 2.5mm as suggested by 
Sonksen et al(89). The foreskin was retracted for uncircumcised 
subjects and the Ferticare® vibrator started at the optimised settings 
as above for the initial attempt at VE.  The vibrations were applied to 
the lower part of the glans and frenulum on the ventral side of the 
penis (Figure 2.7). The subject was warned that a feeling of 
constriction in the chest or a throbbing headache were signs that he 
might be going autonomic, in which case the investigator must be 
alerted at once as the procedure must then be stopped immediately. 
The subjects were offered Nifedipine before the procedure but most 
declined. However, it was ensured that it was available in case a 
subject developed autonomic dysreflexia. 
If the first attempt at VE was unsuccessful a gap of 1 to 2 minutes 
was given and then the process was repeated. The parameters on 
the Ferticare® vibrator were then increased to a frequency of 110 Hz 
and the amplitude to 3.5mm. The procedure was repeated again for 
 82 
2 to 3 minutes.  A maximum of 6 cycles were performed if ejaculation 
did not occur. However, no maximum number of attempts were set if 
the initial attempt was unsuccessful. The penile skin was evaluated 
for damage before each set of vibrations. Obviously, if there were 
any adverse effects i.e. to the skin or the patient generally feeling 
unwell then the procedure was stopped immediately.  All the adverse 
events were documented. It is to be emphasised that only antegrade 
samples were collected. Hence, if the subject felt spasms in the 
lower limbs and abdomen which are thought to be a sign of 
ejaculation no attempt was made to evaluate if the subject had 
ejaculated in a retrograde fashion. This was undertaken to ensure 
that all the collected and hence, evaluated semen samples are not 
mixed with urine for standardization of results. Also, this was in 
keeping with line with previous studies by other 
investigators(15;17;45;107;115;165) 
 
The baseline and the final evaluation at 3 months for all subjects, 
both in study and control arms was performed in the laboratory. In 
addition, the monthly evaluations at one and two months for the 
subjects in the study arm were also undertaken in the laboratory. 
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Figure 2.7: Vibro-ejaculation with the investigator on the patient’s 
right side and the vibrator placed underneath the glans 
 
 
  
 84 
2.7.4 Collection of semen specimen 
 
 
The assistant standing on the left side with a wide mouthed container 
collected the ejaculate. To ensure accurate evaluation, the assistant 
made sure that the whole of the sample was collected. The patients 
were offered to wear a condom before starting VE but most refused. 
  
2.7.5 Safe handling of the semen sample 
 
The subjects were not screened for infectious diseases (Hepatitis, 
Acquired Immunodeficiency Syndrome or Herpes Simplex). Hence, 
the semen sample was thus treated as a biohazard. Gloves were 
worn whilst handling the samples. The semen sample was 
immediately processed in our laboratory and the specimen was 
discarded according to the hospital protocol. The safety guidelines 
for the Andrology laboratory were strictly observed as per WHO 
guidelines (Appendix VII).  
 
2.7.6 Loan of Ferticare® personal vibrator 
 
The subjects who were randomised to the study arm were supplied 
with the Ferticare® vibrator. This was an expensive piece of 
equipment and hence, the subjects were asked to sign a form stating 
that they would be charged if they lost the vibrator.   
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2.8 Semen analysis 
 
The semen analysis was performed according to the WHO 
recommendations(22). The semen underwent both macroscopic and 
microscopic evaluations as described below. 
 
2.8.1 Macroscopic examination  
 
The following parameters were evaluated during the macroscopic 
examination. 
 
2.8.1.1 Liquefaction 
 
Normally the semen sample liquefies within 15 minutes.  However it 
may take up to an hour for it to liquefy, especially in SCI patients.  
The liquefaction time was set at 30 minutes in the laboratory as a cut 
off between normal and abnormal liquefaction.  If the sample 
contained jelly like grains it was stirred gently so as to reduce errors 
in determining sperm concentration(170) but it was not vigorously 
shaken. However, if the sample did not liquefy within 30 minutes this 
was documented. No additional measures such as mechanical 
mixing or enzyme digestion were used to facilitate liquefaction.  
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 2.8.1.2 Appearance  
 
This was examined after the liquefaction had been assessed. A 
normal sample should be grey and homogenous.  Any change in 
colour i.e. black, brown, or red was noted.   
 
2.8.1.3 Volume 
 
This was assessed by pouring the semen into a calibrated container.  
As plastic syringes are thought to affect sperm motility they were not 
used for the assessment of volume.   
 
2.8.1.4 Viscosity 
 
The viscosity of the semen was assessed by gently aspirating it into 
the plastic pipettes.  It was then allowed to drop by gravity and the 
pattern of the droplets was observed to assess the viscosity. Normal 
semen should drop as discreet drops.  If the viscosity is abnormal 
then a long thread is formed which extends from the pipette all the 
way down to the base of the collecting flask.  It is generally 
recommended that the length of the thread should be no longer than 
2cms. Like liquefaction, if the sample was viscous this was 
documented but no additional measures were used to reduce 
viscosity.   
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2.8.1.5 pH 
 
The pH was assessed by putting a drop of the semen on the pH strip. 
Strips from Bayer® were used for this purpose. It was read after 30 
seconds according to the calibrations guide supplied with the pH 
strips.   
 
2.8.2 Microscopic examination  
 
The motility, forward progression, count and morphology of the 
ejaculate were assessed with the help of a compound microscope.   
 
2.8.2.1 Preparation of sample for analysis of motility and 
forward progression 
 
It has been suggested that the size of the cover slip should be the 
same for the purpose of standardisation.  A 10 micro litres volume of 
semen was placed in the centre of a clean slide with a positive 
displacement pipette.  This was covered with the standard cover slip.  
It was ensured that the cover slip spread the drop of semen evenly 
onto the slide.  It was always confirmed that no air bubbles were 
trapped between the cover slip and the slide.  In case this was noted 
the slide was discarded and a fresh one prepared.  Two slides were 
made, one for each observer. It was ensured that the two observers 
did not study each other’s preparations. 
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Once the slides were satisfactorily prepared, they were left to stand 
for 1 minute.  During this time the microfilm heated stage was 
warmed to 37° C.  The laboratory temperature was set at around 23 - 
25° C.  Once the heated stage reached a temperature of 37° C it was 
checked with the control slide.  It changed its colour from black to 
green.  At this point the heated stage warmer was placed onto the 
slide holder of the compound microscope.  The prepared slide was 
seated in the stage warmer.  The initial viewing was performed at a 
100 magnification (10 X objective & 10 X ocular).  Once a general 
view was obtained it was then decided to set the magnification for 
final assessment of motility and forward progression depending upon 
the sperm agglutination and the evenness of spermatozoa on the 
slide.   
 
2.8.2.2 Assessment of sperm motility 
  
A simple grading system was used for the assessment of sperm 
motility.  This was performed very carefully. At least 5 microscopic 
fields were randomly assessed, half a centimetre from the edge of 
the cover slip. Two slides with 10 micro litres of semen were 
prepared.  The motility was assessed independently by 2 observers 
(Figure 2.8). A total of 200 spermatozoa were classified by each 
observer. Sperm motility was expressed as a percentage of the total 
sperms present (0% - 100%). The average percentage and the 
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difference between the percentages as assessed by the 2 observers 
were plotted on the graph (appendix VIII) as suggested in the WHO 
manual.  For example if percentage motility by the 2 observers were 
60% and 35%. The average would be 47.5% and the difference 
would be 25%. Once this is plotted on the graph it would appear that 
for 200 spermatozoa a 10% difference could be expected. This 
difference here was 25%, so it cannot be accepted. These slides 
were discarded and fresh slides were prepared.  
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Figure 2.8: Slide to assess the motility and forward progression of 
sperms (under microscope) 
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2.8.2.3 Assessment of forward progression  
 
The forward progression of the sperms was graduated on a scale of 
0 to 3. The progression was classified as non-progressive - 0, 
sluggish -1, good forward progression -2 and a rapid progression -3. 
The forward progression was assessed at the same time as motility 
assessment. This was assessed in the same 200 spermatozoa along 
with the motility. It was performed independently by 2 observers. If 
there was a difference between the 2 observations then this was 
disregarded and fresh slides were prepared. 
  
2.8.2.4 Assessment of sperm count  
 
The sperm count analysis was performed with a haemocytometer 
after adequate dilution and fixation with formalin based solution. Two 
separate preparations were made on either side of the 
haemocytometer.  A 1 to 20 dilution was usually performed with a 
normal displacement pipette (Eppendorf). The diluent is prepared by 
adding distil water, sodium bicarbonate and formalin (WHO manual). 
The neubauer chamber of the haemocytometer was fixed with a 
cover slip.  The cover slip was pressed firmly so as to develop 
newton rings between the 2 glass surfaces.  The semen mixed with 
formalin was allowed to stand for 5 minutes and stirred gently so as 
to get a uniform concentration.  Then 10 micro litres of the mixed 
specimen were added to each part of the counting chamber of the 
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haemocytometer with a pipette.  A small drop was placed on the side 
and with a capillary action it spread underneath the cover slip. The 
counting was performed either at 200 or 400 magnifications. Only 
complete spermatozoa with both a head and tail were counted (figure 
2.9).  All other forms i.e. pinheads and tailless were eliminated.   
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 Figure 2.9: Assessment of sperm count (under microscope) 
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The central scale of the neubauer haemocytometer contained 25 
large squares.  Each of these squares was divided into16 small 
squares (Figure 2.10). If there were less than 10 spermatozoa in a 
large square then all the 25 squares were counted.  If there were 10 
to 40 spermatozoa then 10 large squares were assessed and if the 
sample contained more than 40 spermatozoa in a large square then 
4 outer and 1 central square was counted. As a rule, if the sperms 
were crossing the lines only the ones on the upper and left hand side 
were counted.   
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    Figure 2.10: Neubauer chamber of a haemocytometer 
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An attempt was made to count duplicates of 200 spermatozoa by 2 
independent observers on either side of the neubauer 
haemocytometer. The count was calculated according to the dilution 
and conversion factors for the neubauer haemocytometer as 
specified in the WHO manual (figure 2.11). The average count was 
checked across the table for a given dilution i.e 1;20. Then the 
conversion number was noted from the number of the large squares 
counted. This provided the count in millions per ml. This was 
performed separately for both observers. The sum of the 2 counts by 
the observers and the difference between them was calculated. This 
was plotted on the graph used for accurate calculation of sperm 
count as per WHO guidelines (appendix IX). If the difference was 
greater than expected from the graph values then this was discarded 
and fresh slides were prepared. No special processing techniques 
were utilised if the number of the spermatozoa was low. The sample 
was not centrifuged.  
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Figure 2.11: Dilution and conversion factors for analysis of sperm 
count- adapted from WHO manual (22) 
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2.8.2.5 Assessment of sperm morphology  
 
Two slides were prepared for duplicate analysis of sperm 
morphology. The slides were washed in ethanol and dried. 10 micro 
litres of sperms were dropped on the slide.  A second slide was 
placed on top so that the drop spread evenly between the 2 slides. It 
was ensured that there were no air bubbles between the 2 slides.  
The slides were gently pulled apart and 2 smears were obtained 
simultaneously.  The slides were allowed to dry in air and then fixed.  
Papanicolaou (PAP) staining:  A PAP stain was used for the staining 
of the spermatozoa.  It stained the head, the acrosome along with the 
central piece, the cytoplasmic droplet and lastly the tail.  The 
composition of the PAP stain is shown in appendix V.  The head is 
stained in pale blue in the acrosomal region. The post-acrosomal 
region is stained dark blue.  The mid-piece is stained red and the tail 
is bluish.  The cystoplasmic droplet is stained green (figure 2.12).   
 
No additional techniques were employed to improve the sperm 
concentration or decrease the viscosity by removal of seminal 
plasma or addition of normal saline. The slides were prepared with 
the available sample. 
 
The classification for assessment of sperm morphology was: 
1- The head should be oval. 
2- The acrosome should comprise 40 to 70% of the head area. 
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3- The mid piece should be 1 ½ times the length of the head and 
attached axially to the head. 
4- The cytoplasmic droplet should be less than half the size of the 
head. 
5- The tail should be straight, uniform and uncoiled. 
All the borderline forms were classified as abnormal(171). The 
various abnormalities noted are shown in appendix X.  
For counting the morphology only the spermatozoa with complete 
head and tail were evaluated.   
Once the slides had been prepared for morphology and dried they 
were placed in the slide chamber underneath the Ziess microscope.  
100 oil immersion lens was used.  200 consecutive spermatozoa 
were counted and the percentage of the normal sperms by the strict 
criteria described above was noted separately.  This was performed 
on two slides by two independent observers. The average 
percentage of the 2 observers and the difference between the 
percentages was calculated. This was plotted on the same graph 
used for assessment of motility (appendix VIII). The final calculation 
was performed in a similar fashion. If the difference was outside the 
expected range according to the WHO guidelines(22) then these 
were discarded and fresh slides prepared. 
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Figure 2.12: assessment of sperm morphology under microscope 
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2.9 Statistical design to test the hypothesis 
 
The study was set up to test if repeated VE would improve the quality 
of sperms following SCI in men. There are various semen 
characteristics that can be evaluated according to the WHO 
guidelines including volume, count, morphology, motility and forward 
progression. Various investigators (15;17;106;107;115) have 
evaluated count, morphology, motility and forward progression whilst 
investigating the effects of repeated ejaculations on the quality of 
sperms in SCI men. It was decided to evaluate the same 
characteristics but choose motility as the primary factor for statistical 
analysis on advice of the statistician. Only one parameter had to be 
selected to ensure that sufficient number of subjects can be recruited 
in both arms for the study to be adequately powered to detect a 
difference in this parameter. 
It was determined that a difference in motility of 20% between the 2 
arms would be considered significant. There was no reference 
guidance available from the previous studies above to base our 
assumption, hence it was thought that if this difference was detected 
it could be considered as significant. The statistician calculated that 
to rule out the probability of showing no difference when one exists 
with a power of 80% (type II error) and to rule out a probability of 
showing a difference when none exists (type 1 error) with 95% 
confidence it would require 9 patients in each arm.  
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A paired Student t-test was used to calculate the statistical 
significance between the baseline and 3 months semen parameters 
in both the study and control groups. A p value of <0.05 was taken as 
significant. Contingency tables were used to evaluate other data with 
Chi-square test for significance.    
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3 RESULTS 
 
3.1 Overall account of subjects 
 
A total of 79 subjects agreed to participate in the study. Forty two 
(53%) subjects were successfully ejaculated with the Ferticare® 
personal vibrator. The remaining 37 were unsuccessful in producing 
an antegrade ejaculate even after multiple attempts. Eight of the 42 
successful subjects decided not to participate after baseline 
evaluation. 
The remaining 34 were randomised into study and control arms. The 
37 non-responders were referred for EEJ after appropriate 
counselling about whether they wanted to explore further the status 
of their sperms. 
The mean age of the subjects at injury was 28 years (range 11- 47 
years) and the mean age at procedure was 42 years (range 26 - 63 
years).  The mean duration since injury was 7.7 years (range 0.5 – 
44 years). Thirty nine subjects had injury at cervical level, 25 subjects 
had injury at thoracic levels T1-T7 whilst 15 had an injury level 
between T7-T10.  There were 41 complete and 38 incomplete 
injuries.     
45 subjects were performing SIC for bladder management.  17 
patients had a SPC, 8 were voiding on urge, 8 were reflex voiding 
whilst 1 patient had a SARS. 
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3.2 Comparison between responders and non-responders 
 
The 37 subjects who did not ejaculate in an antegrade fashion were 
labelled as non-responders for the purpose of this study. All the non-
responders were given an opportunity to re-try the procedure. The 
majority had a minimum of 2 attempts. One subject had 6 attempts, 
whilst 7 had only 1 attempt. Of the 7 in whom only 1 attempt was 
made, 1 developed autonomic dysreflexia, whilst the remaining 6 did 
not find the experience comfortable. Some of the non-responders 
were brought back after a few days to have a second attempt. 
However, of the subjects who were unsuccessful initially none 
managed to produce an antegrade sample with repeated attempts. 
The probable reasons for this will be discussed later on. 
 
3.3 Predictors for successful ejaculations 
 
 
The demographics were compared between the responders and the 
non-responders to evaluate the predictors of success. There was no 
statistical difference between the age at injury, age at procedure or 
the time since injury. The time since injury varied between 0.5 to 27 
years in both groups. This is summarized in the table 3.1 below. A 
parametric non paired, two tailed test was used to evaluate for 
significance. 
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Parameter Responders Non-Responders p value 
Age at Injury 28.02 (± 7.55) 29.54 (± 8.96) 0.42 
Age at 
procedure 
42.62 (± 8.56) 43.04 (± 7.06) 0.83  
Time since 
injury 
6.52 (± 5.82) 8.96 (± 9.65) 0.17 
 
Table 3.1: Comparison of age at injury, age at procedure and time 
since injury between responders and non-responders 
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The level of injury, completeness of injury and the bladder 
management were compared between the responders and non-
responders by Contingency tables. A Chi-Square test was used to 
evaluate for significance. The results are described for level of injury 
in table 3.2, completeness of injury in table 3.3 and bladder 
management in table 3.4 below. 
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Table 3.2: Level of Injury 
 C1-C7 T1-T7 T7-T10 
Responders 20 13 9 
Non-responders 19 12 6 
Chi-square value 0.35, p=0.84 
 
 
 
 
 
Table 3.3: Completeness of injury 
 Complete Incomplete 
Responders 17 25 
Non-responders 24 13 
Chi-square value 4.69 p=0.03 * 
 
 
 
 
 
Table 3.4: Bladder Management 
 SIC SPC Urge Reflex SARS 
Responders 28 7 3 3 1 
Non-responders 17 10 5 5 0 
Chi square value 5.372, p=0.25 
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It appears that the only statistically significant factor influencing 
success with VE in an antegrade fashion was the completeness of 
injury. An incomplete injury afforded a better chance than a complete 
injury for success with VE.  
 
It was also tried to evaluate if the BCR or the HR could predict a 
successful outcome of the procedure. Unfortunately, these 2 tests 
could only be performed in 33 subjects by both the observers and 
hence these were not evaluated on the final analysis. These were 
performed in 17 responders and 16 non-responders. The BCR was 
positive in 16/17 responders and 12/16 non-responders. The HR was 
positive in 13/17 responders and 9/16 non-responders. There was a 
trend for both the reflexes to be positive in responders but regrettably 
no definite conclusion could be drawn as full data could not be 
obtained. 
 
3.4 Summary of total subjects attending for screening  
 
Forty two from a total of 79 subjects (53%) successfully VE and were 
invited to participate in the study according to the protocol. However, 
8 of these subjects declined to take part in the study. The majority 
attended for screening as they wanted to find out if they would 
ejaculate with this method. Some subjects, after discussion with their 
partners, decided not to enter the study as they felt that they would 
not be able to fulfil the requirements of the study protocol. 
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The remaining 34 subjects agreed to participate in the research 
project. Eighteen subjects were randomised to the study and 16 to 
the control arm. Of these 34 subjects 25 completed the entire study 
according to the protocol. 12/18 subjects completed the study arm 
whilst 13/16 subjects completed the control arm of the project. 
 
3.5 Demographics of subjects entering the project  
 
A total of 34 subjects entered the study. Eighteen subjects were 
randomised to the study and 16 to the control arms. The 
demographics details of these subjects is summarised in table 3.5.   
 
 
 
 
 
 
 
 
 
 
Table 3.5: Demographics of 34 subjects randomised to the project 
(next page) 
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PPPt no 
 
Age at 
injury 
(yrs) 
Age at 
procedure 
(yrs) 
Time since 
injury (yrs) 
Level of 
Injury 
Complete / 
Incomplete 
Bladder 
Management 
Project 
status 
1 34.0 48.0 5.75 C6 Incom SIC Study 
completed	  
2 29.0 47.0 9.0 T2 com SIC Study 
completed	  
3 35.0 47.0 4.0 T4 com SPC Study  
completed	  
4 47.0 55.0 1.5 T5 com SIC Study  
completed 
5 37.0 45.0 0.6 C5 Incom SIC Study  
completed	  
6 17.0 43.0 17.0 C4 Incom SIC Study  
completed	  
7 39.0 54.0 5.0 T5 incom Urge voiding Study  
completed	  
8 29.0 38.0 1.5 T8 com SIC Study  
completed	  
9 21.0 31.0 2.5 T4  incom SIC Study  
completed	  
10 30.0 52.0 15.0 C5 com SIC Study  
completed	  
11 29.0 53.0 19.0 C5 com SARS Study  
completed	  
12 31.0 46.0 7.0 T7 com SIC Study  
completed	  
13 19.0 30.0 3.5 T6 incom SIC Control  
completed	  
14 32.0 42.0 2.4 T1 com SIC Control  
completed	  
15 24.0 37.0 4.2 C6 com SPC Control  
completed	  
16 31.0 47.0 8.0 C4 incom Urge voiding Control  
completed 
17 26.0 44.0 10.0 C5 Incom SPC Control  
completed	  
18 41.0 52.0 1.5 T5 Incom SIC Control  
completed	  
19 33.0 45.0 4.0 C5 incom SPC Control  
completed	  
20 38.0 50.0 4.4 T3 Com SIC Control  
completed	  
21 35.0 45.0 1.5 C5 Com SPC Control  
completed	  
22 13.0 34.0 13.0 C4 Incom SPC Control  
completed	  
23 21.0 29.0 1.5 T5 incom SIC Control  
completed	  
24 34.0 47.0 7.0 C5 com Reflex void Control  
Completed	  
25 21.0 31.0 4.0 C6 incom SIC Control  
Completed 
26 36.0 47.0 3.0 T5 com SIC Drop out –  
Study	  
27 23.0 41.0 10.0 C4 incom SIC Drop out –  
Study	  
28 20.0 29.0 1.25 T10 com SIC Drop out – 
Study 
29 18.0 52.0 27.0 T5 incom SIC Drop out –  
study 
30 18.0 26.0 0.5 C5 incom SIC Drop out –  
study 
31 28.0 36.0 2.0 T7 com SIC Drop out – 
study 
32 17.0 32.0 7.0 T10 com SIC Drop out –  
control 
33 24.0 40.0 7.2 T7 com SIC Drop out –  
control	  
34 17.0 29.0 4.5 C5 incom SIC Drop out –  
control 
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25 of the above 34 subjects completed the study. The study and 
control arms appear to be well matched as shown in table 3.6 below. 
There was no significant difference between the study and control 
group with regard to the patient’s age, time since injury, level of 
injury, completeness or bladder management. 
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Table 3.6: Subject Demographics – study and control arms (25 patients 
completing project) 
 
 
 
 
 
Parameter Study Group Control Group p value 
Number 12 13  
Age at Procedure 
(years) 
46.58 (± 6.95) 41.00 (± 7.89) 0.07 
Time since injury 
(years) 
7.32 (± 6.38) 5.0 (± 3.54) 0.27 
Level of Injury    
C1-C7 5 9 Chi-square 4.109 
T1-T6 5 4 P=0.13 
T7-T10 2 0  
Complete 6 5 Chi-square=3.23 
Incomplete 6 8 P=0.58 
Bladder 
Management 
   
SIC 9 6 Chi-square=5.24 
SPC 1 5 P=0.26 
Urge 1 1  
Reflex 0 1  
SARS 1 0  
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3.6 Analysis of subjects dropped from the project 
 
Nine of 34 subjects (26%) did not fulfil the entire research protocol. 
Six of 18 subjects (33%) in the study arm dropped out after entering 
the study. The majority of these 4/6 (66%) could not continue to 
ejaculate regularly after entering the study at various intervals. They 
were all trying to use the vibrator as per the instructions. We did not 
try to evaluate if they were having retrograde ejaculations as it would 
not have been possible to objectively compare the ejaculate with the 
antegrade samples.  One subject was unwell and could not continue 
with repeated ejaculations on weekly intervals as per protocol. The 
6th subject neither attended for monthly evaluations nor for the final 
analysis at 3 months. He could not be contacted even after repeated 
attempts. It could not be ascertained if he was following the protocol.  
 
In the control arm 3/16 (18%) subjects dropped out. One was 
admitted to another hospital with long term illness and was deemed 
unsuitable to travel for the 3 month evaluation. The remaining 2 
patients could not be contacted in spite of repeated attempts to 
request them to come for the final analysis at 3 months. 
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3.7 Results of the experiment in study and control arms 
 
Twenty five subjects (12 in study and 13 in control arm) completed 
the project. The changes in various parameters studied are depicted 
in the graphs below.  
 
3.7.1 Volume  
 
The changes in the volume of the ejaculate in the study arm (figure 
3.1a) and control arms (figure 3.1b) are depicted in the graph below. 
There does not appear to be any significant change in volume over 
the 3 months in either the study or the control groups. This is shown 
in figure 3.2. 
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Figure 3.1a: Individual change in volume baseline and 3 months in 
study group (n=12) 
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Figure 3.1b: Individual change in volume baseline and 3 months in 
control group (n=13)
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Figure 3.2: Graph denoting mean volume changes (error bars denote 
SD) in study and control arms at baseline and 3 months
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3.7.2 pH  
 
The pH of the ejaculate in the study (figure 3.3a) and the control 
(figure 3.3b) arms depicted a tendency to increase over the duration 
of the project. On statistical comparison there was no significant 
difference in the pH in the study arm over 3 months. However, there 
was a statistical increase in the pH of the control group at the end of 
the study period as shown in figure 3.4 below. 
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Figure 3.3a: Individual change in pH baseline and 3 months in study 
group (n=12) 
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Figure 3.3b: Individual change in pH baseline and 3 months in control 
group (n=13) 
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Figure 3.4: Graph denoting mean pH changes (error bars denote SD) 
in study and control arms at baseline and 3 months 
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3.7.3 Motility  
 
The motility of sperms in the study group (figure 3.5a) changed for 
most of the subjects. This did not seem to a follow a definite pattern. 
The motility in the control group (figure 3.5b) was also variable 
without any definite pattern. 
Overall, the motility of sperms did not change significantly in either 
the study or control arms on statistical comparison between the 
baseline and the 3 months sample in each group as shown in figure 
3.6. 
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Figure 3.5a: Individual change in motility baseline and 3 months in study 
group (n=12) 
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Figure 3.5b: Individual change in motility baseline and 3 months in control 
group (n=13) 
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Figure 3.6: Graph denoting mean changes in motility (error bars 
denote SD) in study and control groups at baseline and 3 months 
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3.7.4 Forward progression   
 
The forward progression of sperms improved in the study arm (figure 
3.7a) with repeated ejaculations over the duration of the study period. 
The control arm (figure 3.7b) did not demonstrate any significant 
improvement in forward progression between baseline and the end of 
the study period. At 3 months there was a statistically significant 
increase in forward progression in the study arm but there was no 
significant change in the control arm as shown in figure 3.8. 
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Figure 3.7a: Individual change in forward progression baseline and 3 
months in study group (1-2:(2);1-3;(2);2-1:(1);2-2:(1);3-3(1);1-1:(1);2-
3:(2);0-0:(2):– n=12) 
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Figure 3.7b: Individual change in forward progression baseline and 3 
months in control group (2-3:(2);1-0:(1);1-1:(5);2-1:(1); 1-2:(1); 0-0:(2); 0-
1:(1):- n=13) 
 
 
 
 126 
 
 
 
 
 
Baseline 3 months Baseline 3 month
0
1
2
3
4
Study                   Control
Fo
rw
ar
d 
Po
rg
re
ss
io
n *
 
Figure 3.8: Graph denoting mean changes in forward progression 
(error bars denote SD) in study and control groups at baseline and 3 
months  
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3.7.5 Morphology  
 
The changes in morphology of sperms in the study group are shown 
in figure 3.9a. The morphology of the control group is depicted in 
figure 3.9b. There was a statistically significant improvement in the 
morphology of sperms in the study group over the 3 month study 
period. On the other hand, the morphology did not change 
significantly in the control group over this time as shown in figure 
3.10. 
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Figure 3.9a: Individual change in morphology baseline and 3 months in 
study group (n=12) 
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Figure 3.9b: Individual change in morphology baseline and 3 months in 
control group (n=13) 
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Figure 3.10: Graph denoting mean changes in morphology (error 
bars denote SD) in study and control groups at baseline and 3 
months 
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3.7.6 Count   
 
The count in the study group (figure 3.11a) changed considerably 
between different subjects but this did not seem to follow a definite 
pattern. 
The count in the control group (figure 3.11b) also appeared to 
change without any definite pattern. 
Overall, there was no significant change in the sperm count in either 
the study or control groups over the 3 month study period as shown 
in figure 3.12. 
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Figure 3.11a: Individual changes in the count baseline and 3 months in 
study group (n=12) 
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Figure 3.11b: Individual change in count baseline and 3 months in control 
group (n=13) 
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Figure 3.12: Graph denoting mean changes in count (error bars 
denote SD) in study and control arms at baseline and 3 months 
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3.7.7 Liquefaction 
 
Overall, the semen samples in the project liquefied satisfactorily 
during the study period. There was no significant difference in the 
liquefaction time between the study and the control groups (figure 
3.13). 
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Figure 3.13: Comparison of liquefaction- study and control groups at 
baseline and 3 months 
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3.8 Detailed analysis of semen parameters in the study arm at 
monthly intervals 
As there is a huge variation in various semen parameters in SCI 
men, further analysis were performed in the study group at monthly 
intervals to record the rate of change of various parameters. This 
was particularly important to evaluate if the improvement in some 
parameters was consistent over the duration of the study as one 
would expect with repeated ejaculations or is it that the change was a 
matter of chance.  
A regression analysis was performed for each variable. A linear 
regression was undertaken. The r2 value suggests how good a fit the 
data is to the straight line, the closer one gets to 1 the better the fit. 
The significance value is whether the slope is significantly not 
horizontal. If it is horizontal there is no relationship between the X 
and Y data. If it is significantly not zero then there is some 
relationship between the X and Y data. 
 
3.8.1 Volume 
The volume in the study arm shows some variation but overall it does 
not appear to vary widely in most subjects (Fig 3.14). However, on 
linear regression curve (Fig 3.15) there seems to be a significant 
decrease over the 3 months. On statistical comparison with each 
subject separately there was no significant decrease in volume as 
shown in table 3.7.   
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   Figure 3.14: Volume in study arm – monthly over 3 months 
 
	  
	  
 Figure 3.15: Volume in study arm with linear regression curve         
(r2 = 0.0116. Slope significantly non-zero p=0.034 
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3.8.2 pH 
There was no particular pattern on the individual curves for this 
parameter (Fig 3.16) with some increasing and others decreasing. 
This was confirmed on the linear regression curve which did not 
reveal any significant change over 3 months (Fig 3.17). This is 
consistent with the statistical analysis in individual subjects between 
baseline and 3 months period as shown in table 3.7.   
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         Figure 3.16: pH in study arm – monthly over 3 months 
 
              
 
 
 
Figure 3.17: pH in study arm with linear regression curve                
(r2=0.0035) 
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3.8.3 Motility 
There appears to be quite a variation in the motility of individual 
subjects. This appears to both increase and decrease over 3 months. 
Also, it seems that in a number of individuals it changes on a month 
to month basis. The cause of this variation is difficult to ascertain as 
there was no change in the management of these individuals. There 
was no significant change seem in the linear regression curve in the 
motility over the 3 month period. This is consistent with findings of 
statistical analysis between individual subjects at baseline and 3 
months as shown in table 3.7.   
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Figure 3.18: motility in study arm – monthly over 3 months 
	  
 
 
Figure 3.19: Motility in study arm with linear regression curve          
(r2 = 0.0002)	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3.8.4 Forward progression 
There appears to be a wide variation in the forward progression of 
individual subjects on a monthly basis. However, there does not 
seem to be a pattern to individual changes with some increasing and 
others decreasing on a monthly basis as shown in Figure 3.20. The 
accompanying linear regression curve does not demonstrate any 
significant change (fig 3.21). This is in contradiction to the individual 
changes in subjects between baseline and at 3 months as shown in 
table 3.7. On reason can be that the monthly variation resulted in 
picking up the difference at set points rather than there was an 
overall increase in forward progression of the sperms. Alternatively, 
as this was measured in numbers (1-4), this led to the difference not 
being detected on the linear regression curve. 
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Figure 3.20: forward progression in study arm – monthly over 3 
months 
 
 
 
 
 
Figure 3.21: forward progression in study arm with linear regression   
curve (r2 = 0.072)	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3.8.5 Morphology 
The morphology also showed considerable variation in individual 
subjects over the study period (Fig 3.22). It appears that mostly it 
increased but again this was not consistent in every subject. The 
accompanying linear regression curve does reveal a significant 
improvement in this parameter over 3 months (Fig 3.23). This is in 
agreement with the individual analysis of morphology in study and 
control arms between baseline and 3 months as shown in table 3.7.  
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Figure 3.22: morphology in study arm – monthly over 3 months 
 
 
  
 
Figure 3.23: morphology in study arm with linear regression curve   
(r2 = 0.106. slope significantly non-zero p=0.04) 
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3.8.6 Count 
The count demonstrated a wide variation in individual subjects on a 
monthly basis with a decrease in most cases (Fig 3.24). The linear 
regression curve reflects this pattern by revealing no significant 
change over the 3 month period (Fig 3.25). This is consistent with the 
statistical analysis in individual cases at baseline and 3 months as 
shown in table 3.7. 
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        Figure 3.24: count in study arm – monthly over 3 months 
 
 
Figure 3.25: count in study arm with linear regression curve              
(r2 = 0.012) 
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3.9 Statistical comparison of results between study and control 
arms 
 
Two parameters, morphology and forward progression showed a 
statistically significant increase in the study arm but not in the control 
arm. There was a significant increase in the forward progression of 
the sperms. Additionally, the morphology of sperms improved 
significantly over the study period. The analysis was performed with 
a paired Student’s t test, 2 tailed and a significance of <0.05. All the 
other variables, including motility, did not improve significantly. 
Surprisingly, the pH increased significantly in the control group. The 
results are summarised in the table 3.7 below. 
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Parameter	   Study	  Group	   Control	  Group	  
	   Baseline	   3	  month	   P	  value	   Baseline	   3	  month	   P	  value	  
Volume	  (ml)	   2.87	  (±	  
1.15)	  
1.93	  (±	  
0.96)	  
NS	   2.14	  (±	  
1.19)	  
1.75	  (±	  
0.99)	  
NS	  
pH	   7.88	  (±	  
0.43)	  
8.24	  (±	  
0.80)	  
NS	   7.75	  (±	  
0.5)	  
8.14	  (±	  
0.62)	  
0.0027	  
**	  
Motility	   31.0	  (±	  
31.14)	  
29.58	  (±	  
21.16)	  
NS	   9.61	  (±	  
9.23)	  
13.38	  (±	  
16.8)	  
NS	  
Forward	  
Progression	  
1.33	  (±	  
0.89)	  
1.92	  (±	  
1.17)	  
0.05	  *	   1.00	  (±	  
0.71)	  
1.15	  (±	  
0.99)	  
NS	  
Morphology	   16.0	  (±	  
9.22)	  
26.75	  (±	  
15.62)	  
0.006**	   20.85	  (±	  
10.21)	  
17.15	  (±	  
7.44)	  
NS	  
Count	   72.08	  (±	  
49.74)	  
59.08	  (±	  
53.21)	  
NS	   95.69	  (±	  
89.01)	  
68.77	  (±	  
54.85)	  
NS	  
Liquefaction	   1.08	  (±	  
0.29)	  
1.42	  (±	  
0.51)	  
NS	   1.15	  (±	  
0.38)	  
1.31	  (±	  
0.48)	  
NS	  
Table 3.7: statistical analysis in study and control arms at baseline and at 
3 months (Within group Student’s paired t test, 2 tailed, significance 
p<0.05) 
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3.10 Statistical comparison of results within study and control 
arms 
As already described in section 3.5 above no significant difference 
between the study and control group with regard to the patient’s age, 
time since injury, level of injury, completeness or bladder 
management was detected. Further analysis were performed to 
check if the groups were also comparable at baseline and at 3 
months in respect to semen characteristics. This is summarised in 
table 3.8 below.   
There was no statistical difference within the groups at baseline and 
at 3 months for any parameter except motility. There was a 
significant difference between sperm motility of the subjects. This 
was evident both at baseline and at 3 months. It is difficult to explain 
the isolated difference in this particular parameter as the groups were 
comparable in all other parameters including demographics. One 
explanation can be that there is a wide variation in sperm 
characteristics and this became evident during a controlled study. 
However, as there was no significant improvement in motility within 
the groups it is felt that this particular problem did not affect the 
conclusions of the study.   
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Parameter	   Baseline	   3	  months	  
	   Control	   Study	   P	  value	   Control	   Study	   P	  value	  
Volume	  (ml)	   2.14	  (±	  
1.19)	  
2.87	  (±	  
1.15)	  
NS	   1.75	  (±	  
0.99)	  
1.93	  (±	  
0.96)	  
NS	  
pH	   7.75	  (±	  
0.5)	  
7.88	  (±	  
0.43)	  
NS	   8.14	  (±	  
0.62)	  
8.24	  (±	  
0.80)	  
NS	  
Motility	   9.61	  (±	  
9.23)	  
31.0	  (±	  
31.14)	  
*	  0.0266	   13.38	  (±	  
16.8)	  
29.58	  (±	  
21.16)	  
*	  0.0442	  
Forward	  
Progression	  
1.00	  (±	  
0.71)	  
1.33	  (±	  
0.89)	  
NS	   1.15	  (±	  
0.99)	  
1.92	  (±	  
1.17)	  
NS	  
Morphology	   20.85	  (±	  
10.21)	  
16.0	  (±	  
9.22)	  
NS	   17.15	  (±	  
7.44)	  
26.75	  (±	  
15.62)	  
NS	  
Count	   95.69	  (±	  
89.01)	  
72.08	  (±	  
49.74)	  
NS	   68.77	  (±	  
54.85)	  
59.08	  (±	  
53.21)	  
NS	  
Liquefaction	   1.15	  (±	  
0.38)	  
1.08	  (±	  
0.29)	  
NS	   1.31	  (±	  
0.48)	  
1.42	  (±	  
0.51)	  
NS	  
Table 3.8: Statistical analysis in the study and control groups at baseline 
and at 3 months. (Between groups (non-paired t-test significance > 0.05) 
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3.11 Dropout due to non-compliance with protocol 
 
There was only 1 subject in the study group and 2 in the control 
group who did not comply with the protocol without any valid reason. 
All the other drop outs 5/9 could not complete the study either due to 
being unwell or unable to follow the protocol despite trying i.e failure 
of VE.   
 
3.12 Adverse events 
 
No major complication was noted during the study apart from 1 
patient who developed severe autonomic dysreflexia during the 
procedure which was immediately abandoned. This patient did not 
ejaculate till he developed dysreflexia and was assigned to the failed 
group.  
Three subjects (25%) in the study group developed minor penile 
abrasions secondary to repeated ejaculations but did not require any 
treatment. They continued to perform repeated VE as per protocol. 
One subject reported mild symptoms of dysreflexia but did not 
require any treatment. 
Two subjects in the control group developed mild symptoms of 
dysreflexia during VE. However, they did not require any active 
treatment and the symptoms subsided after ejaculating. 
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4- DISCUSSION 
 
4.1 Summary of results 
 
This study evaluated 79 subjects for success with VE. Forty two of 
the 79 (53%) subjects were successfully VE with the Ferticare® 
vibrator. Thirty four subjects agreed to participate in the project and 
were randomised into study and control arms. The 37 subjects who 
did not ejaculate in an antegrade fashion were labelled as non-
responders. All the non-responders had a minimum of 2 attempts. 
Some of the non-responders were brought back after a few days to 
have a second attempt. In this study none of the subjects who were 
unsuccessful initially managed to produce an antegrade sample at 
the second visit.  
The success of the procedure was not dependent on the age at 
injury, age of procedure or the time since injury. The average age at 
injury was 28 years and the average age at procedure was 42 years. 
The time since injury varied between 0.5 to 27 years in both groups. 
There were 39/79 (49%) subjects with cervical level injury. Twenty 
five (31%) had upper thoracic (T1-T6) and 15 (19%) had a lower 
thoracic (T7-T10) level injury. However, there was no significant 
difference between the responders and the non-responders 
according to the level of injury. 
In the study the method of bladder management did not influence the 
success with VE. Thirty five of the 42 responders (83%) and 27/37 
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non-responders (73%) were emptying the bladder by either SIC or 
with a SPC. There was no significant difference between the two 
groups. 
However, there was a significant difference between the responders 
and non-responders according to the completeness of the injury. In 
this study an incomplete injury afforded a significantly better chance 
of obtaining an antegrade ejaculate as compared to a complete 
injury. 
A total of 34 subjects were entered into the study protocol. Eighteen 
were randomised to the study and 16 to the control arm. Twenty five 
of 34 subjects (74%) completed the entire study. Twelve of 18 (66%) 
subjects in the study arm completed the entire study whilst 13/16 
(81%) in the control arm completed the study. At the end of the study 
there was no statistically significant difference in liquefaction, volume, 
pH, count and motility in the study arm. However, there was a 
statistically significant improvement in the morphology and forward 
progression of sperms in the study arm. On the other hand there was 
no difference in any of the parameters in the control arm at the end of 
the study period apart from pH which increased significantly. 
Hence, this study has shown that repeated VE results in some 
improvement of quality of sperms following SCI in men. The 
characteristics that improve significantly are morphology and forward 
progression. However, the primary variable i.e. motility, thought to be 
one of the main factors in the quality of sperm, did not show a 
significant improvement.  Additionally, a little more than half of SCI 
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patients with injury above T10 produced an antegrade ejaculate. The 
only significant factor determining success of VE in this group was 
the incompleteness of SCI. 
 
4.2 Comparison of results with significant improvement  
 
This study has shown a statistically significant improvement in two of 
the parameters evaluated. The morphology and forward progression 
of sperms improved over the study period of 3 months in the study 
arm but there was no significant change in these parameters in the 
control arm. These results confirm the findings of some previous 
investigators. Beretta in 1989(17) performed repeated VE in 15 
patients weekly for 3 months. He reported a significant improvement 
in motility, morphology and sperm count over the study period. There 
was no comparable increase in volume. Similarly, Siosteen in 
1990(15) performed VE on a weekly basis for more than 4 months in 
16 SCI men. She concluded that the semen volume increased 
significantly as did the forward progression of sperms but there was 
no significant improvement in sperm morphology and motility. She 
also noticed a rise in semen fructose and acid phosphatase 
suggesting an improved function of seminal plasma. Brindley in 
1983(106) also concluded that repeated ejaculations improve semen 
quality in SCI men. On the other hand Sonksen(115) performed the 
longest study to date with VE in SCI men. Nineteen SCI men 
underwent a weekly programme of VE for 1 year. There was no 
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improvement in volume, count, motility or morphology over the period 
of the study. Some investigators have tried repeated EEJ to evaluate 
if this technique improves the quality of sperms in SCI men. Mallidis 
in 2000(166) performed daily EEJ for 4 consecutive days in 9 SCI 
men. He reported improvement in sperm motility and viability by an 
average of 23%. However, Das in 2006(167) performed EEJ in 16 
SCI men at 2-4 weekly intervals. He carried out 3 consecutive 
attempts. He did not find any significant improvement in sperm 
motility or morphology but noticed a significant decrease in semen 
volume. It is interesting to note that none of the studies mentioned 
above provide conclusive evidence of whether repeated ejaculations 
in SCI men improve the quality of sperms. Furthermore in studies 
demonstrating an improvement in some parameters, the improved 
parameters were not consistent across studies. This reveals the 
complexity of the problem in SCI men but does confirm the fact that 
poor quality semen in SCI men is a multifactorial problem. There are 
a significant number of studies in the literature evaluating the sexual 
dysfunction in SCI men(99;172-177). A number of studies have 
investigated the causes of ejaculatory dysfunction and abnormal 
semen characteristics(13;19;96) in SCI men. However, they have 
mostly concentrated on obtaining an ejaculate(14;17;58;74;85;120) 
and identifying the probable causes of poor semen quality like stasis 
of semen, role of urine infections and bladder management rather 
than suggesting remedial steps to improve the semen characteristics. 
There are only a handful of studies as described above which have 
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tried to improve the quality of sperms in SCI men but none were set 
up as a randomised control study. This is the first study that has 
evaluated the effects of repeated ejaculations in SCI men in a 
controlled setting. It has shown that there is an improvement in 
sperm morphology and forward progression but not motility. It has to 
be emphasised that the study was not powered to evaluate the 
statistical difference in forward progression or morphology. As in 
previous studies, it is somewhat difficult to explain why only 
morphology and forward progression improved and not motility, 
which is thought to be an important parameter in sperm 
characteristics. It can be argued that with stagnation and probable 
mixing of sperms with seminal plasma the quality of sperms 
deteriorates. Once the patient starts to perform repeated VE and the 
ejaculatory ducts are cleared then over a period of time the sperm 
characteristics might improve.  It can be postulated that not only the 
individual sperm characteristics but the environment in which they 
are stored (seminal plasma) is equally if not more important. Indeed, 
this can be hypothesised from some acute and chronic studies. In 
Ohl et al (100) canine model serial examination of semen profile and 
spermatogenesis indicated a decline in spermatogenesis and sperm 
motility at 3 weeks but not before this time. It was argued that if this 
continues in chronic phase one would expect a decrease in total 
sperm numbers over time. However, we know that although, the 
motility of sperms in SCI deteriorates over time, there are a 
significant number of sperms in ejaculated specimens from chronic 
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SCI men (21). Hence, it is not clear whether spermatogenesis 
recovers or there is a disorder of sperm storage in seminal vesicle of 
SCI men (91). Furthermore, it has been demonstrated that seminal 
plasma of SCI men is toxic to sperms from able bodied men (150) 
whilst, the motility of sperms of SCI men improved when mixed with 
seminal plasma from able bodied men. Additionally, the sperm 
motility is higher when obtained from vas deferens than from 
ejaculated specimen in the same SCI men (178). The sperms need a 
normal shape and form (morphology) to have a normal motility and 
forward progression. The spermatogenesis takes place in the 
germinal epithelium of the testis and the process takes 64 days in 
humans (34). However, the spermatozoa at this stage are immotile 
and only have a limited capability to fertilize the ovum. The final 
maturation takes place during the epididymal transit which takes 
between 2 to 11 days (35). The sperms are stored in the caudal part 
of epididymis for varying lengths of time depending upon the sexual 
activity. It has been shown that the forward progression of sperms 
improves during the transit through epididymis (36). It can be 
postulated that with repeated VE the ejaculatory ducts can be 
cleared of senescent sperms and over time the quality might 
improve. It can be argued that had the study been carried on for 
longer, there could have been a different impact on the motility of 
sperms. However, it is somewhat different to postulate whether there 
would have been an improvement or the motility might have not 
changed or indeed could have decreased. It has to be admitted that 
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Sonksen in 1999(115) did carry on with VE for a year and did not find 
any significant improvement in sperm characteristics, but the study 
was not randomised. Also there were patients (number not specified 
in the paper) who had an injury for less than 6 months in his study. It 
has been suggested by some investigators that the quality of sperms 
deteriorates following SCI and does not stabilise until 6 months after 
injury (45). It is possible that including patients from this group might 
have skewed the results of the study.  
 
The pH in the control arm increased significantly in this study. There 
was a trend in the study arm towards increased pH but this did not 
reach statistical significance. The reason for this phenomenon could 
not be ascertained. It is understood that if the pH is acidic with 
azoospermia then obstruction of the ejaculatory ducts is a strong 
possibility (WHO manual). However, the significance of basic pH as 
in our study is not known. It was not possible to compare this 
particular factor with other studies in the literature as pH was not 
measured in previous studies.              
 
4.3 Comparison of results with no significant improvement  
 
In this study there was no significant improvement in volume, motility 
and count with repeated ejaculations.  However, Beretta in 1989(17) 
reported a significant improvement in motility and sperm count with 
repeated VE over 3 months. There was no significant increase in 
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volume. On the other hand Siosteen in 1990(15) demonstrated 
significant increase in semen volume but no improvement in sperm 
motility. Sonksen in 1999(115) did not find any improvement in 
volume, count or motility over repeated VE for 1 year. Mallidis in 
2000(166) reported improvement in sperm motility on an average of 
23%. Das in 2006(179) did not find any significant improvement in 
sperm motility but noticed a significant decrease in semen volume. 
In the current study the volume decreased considerably but did not 
reach statistical significance, unlike the Das study above where the 
volume decreased significantly. On the other hand Siosteen reported 
a significant increase in semen volume over a 3 month repeated VE 
programme. The decrease in volume in this study might be related to 
repeated ejaculations but, importantly, like other studies it did not 
evaluate if there was any retrograde ejaculation. Hence, it is a 
possibility that some of the ejaculate was in a retrograde manner, 
accounting for a decrease in volume but this needs to be confirmed 
in later studies.  
The sperm count in this study decreased as demonstrated by 
Sonksen(115) although it did not reach significance in either study. 
The count increased significantly in the study by Beretta(17).  
It is difficult to ascertain the exact cause of decrease in the count. 
However, it has been demonstrated previously that the ejaculations 
might cease after a period of repeated VE(15;96). Certainly, in this 
study 3 of 18 subjects in the study arm stopped VE after a few 
successful initial attempts. It is possible that this phenomenon might 
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in some way account for a decrease in semen volume leading to a 
decrease in sperm count.  
 
4.4 Predictors for success with Vibro-ejaculations 
 
The success rate for VE in this study was 53% (42/79). This is 
somewhat lower than the reported success in previous studies. 
Brindley(79) who popularised this technique reported a rate of about 
60%. There is a large reported range of success in the literature 
varying between 19-91%. One of the reasons can be that over years 
several non-medical vibrators have been used with varying 
output(14;15;17;45;87;88). Sonksen suggested an amplitude of 
2.5mm and a frequency of 100Hz as a predictor of success with 
VE(89). He reported a success of 96% but this included both 
antegrade and retrograde ejaculates. Ohl in 1996 reported a success 
of 65% using the same parameters(16).  
A number of factors were evaluated to determine the predictability of 
success with VE. There was no statistical difference between the 
responders and non-responders when considering age at injury, age 
at procedure or the time since injury, method of bladder drainage or 
level of injury (assuming the level of injury is above thoracic level 10).  
The only significant factor in this study determining success was the 
incompleteness of injury. Sonksen in 1994(89) reported no predictors 
of success as above including the completeness of injury. The only 
factors in his study determining success were the optimised 
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parameters with an amplitude of 2.5 mm and a frequency of 100Hz. 
Unlike the current study the completeness of injury was not a definite 
prognostic factor for obtaining semen by VE according to Brindley 
and Szasz(14;58). Bird et al in 2001(180) reported, like the current 
study, that there is no difference between responders vs non-
responders with regards to age or time since injury. However, they 
carefully investigated the BCR and HR and concluded that if both 
reflexes were present then the success rate for VE was 80%. On the 
other hand it was only 8% if both reflexes were absent. Similarly, 
Brindley(14) noted that the most important factor determining 
success was the presence of HR. Szasz in 1989(58) reported BCR 
as a predictor of success with VE. In the current study the reflexes 
could only be performed in 33/79 patients. The BCR was positive in 
94% and HR in 76% of the responders. Although there was a trend 
for both the reflexes to be positive in the responders, regrettably no 
definite conclusion could be drawn from this study as the full data 
could not be obtained due to the fact that the 2 observers did not 
document the evaluation of both these reflexes independently in all 
subjects.  
 
4.5 Role of seminal fluids in poor semen quality post SCI in men 
 
It has been shown in previous studies and confirmed by the current 
one that no single factor seems to be responsible for the 
deterioration of sperm quality following a SCI. It appears that a 
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combination of various factors leads to a poor sperm quality. Lately, 
attention has turned to the evaluation of seminal plasma as a cause 
of deterioration in sperms following SCI. It is known that there is an 
abnormal prostate and seminal vesicle function in men with SCI(146-
148). It has been demonstrated in another study that lower levels of 
fructose and albumin are present in the semen of SCI men pointing 
to an accessory gland factor in causing deterioration of sperms after 
SCI(56). More evidence that seminal plasma may play a crucial role 
in causing deterioration of sperm quality was demonstrated when it 
was shown that seminal plasma obtained with ejaculate from SCI 
men inhibits the motility of normal sperms from able bodied men. 
Conversely the sperms from SCI men improve their motility if they 
are mixed with the seminal plasma from able bodied individuals(150).  
It has also been shown that the sperms of men with SCI demonstrate 
significantly better sperm motility and viability when aspirated from 
the vas deferens as compared to sperms obtained with VE or 
EEJ(178). A large number of poor quality sperms in the seminal 
vesicle of SCI men have been documented(91). These, obviously 
comprise a major portion of the ejaculate with VE and EEJ. More 
recently, Maher et al(158) employed a nuclear magnetic resonance 
spectroscopy to analyze seminal fluid metabolite and demonstrated 
that uridine is likely to be an essential precursor to metabolites 
required for capacitation and is a potential marker for the prognosis 
of post-SCI functional fertility recovery.  A new term "seminal 
oligouridinosis" was coined to describe this newly identified condition.  
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The above data provides evidence that seminal plasma is also a 
major contributing factor to the deterioration of sperms following a 
SCI.    
 
4.6 Methodological weaknesses 
 
This study was conducted in a hospital out-patients setting with SCI 
men. These patients had complex needs and were looked after by a 
multidisciplinary team. There were a number of limitations observed 
during the study which had to be taken into account to successfully 
complete the project. 
 
4.6.1 Uncontrollable variables 
 
SCI patients are a very heterogeneous population and their care is 
quite complex with input from doctors and specialist nurses. There 
are a number of factors that were difficult to control during the 
experiment as explained below. 
 
4.6.1.1 Enrolment of subjects  
 
All eligible subjects were informed of the study at the institution. 
However, the subjects decided whether they wanted to attend the 
screening. Overall, younger subjects with partners were more 
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interested in evaluating their fertility status. It is difficult to ascertain if 
this in anyway affected the subject sample and affected the outcome. 
 
4.6.1.2 Effect of medications on sperm quality  
 
The SCI men are generally on a variety of medications.There are a 
number of medications which can affect sperm quality. It was 
accepted that it would not be possible to stop the medications for the 
duration of the study. Hence, this limitation was accepted and it was 
anticipated that randomization would minimise the risk of the results 
being affected by this potential restriction. A record of all the 
medications was not kept for the subjects. Furthermore, a 
comparison between the study and the control arm was not made in 
this respect. However, this factor has not been deliberated upon in 
any of the previous studies evaluating semen quality in SCI men. 
 
4.6.1.3 Impact of urine infections on the project  
 
UTIs are not an uncommon occurrence in SCI men. This could have 
become a problem for the study if active subjects had developed 
epididymo-orchitis. Fortunately, no subject in our study developed 
epididymo-orchitis. Subjects who were suffering from a urinary 
infection were not enrolled in the study. However, it was decided that 
if subjects developed a UTI during the study, they would be 
prescribed the appropriate antibiotics but not withdrawn as long as 
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they could VE weekly. A few who developed UTI did not develop any 
systemic signs precluding them from performing weekly VE to fulfil 
the protocol requirements. 
 
4.6.1.4 Weekly vibro-ejaculations at home 
 
It was accepted as part of the protocol that the subjects randomised 
to the study arm would be relied upon to perform weekly VE at home. 
It was expected that the subjects would not only fulfil this requirement 
but also would not try to ejaculate more than once a week. Although, 
the subjects were instructed to try to VE on a set day, it had to be 
accepted that this would not always be possible due to multiple 
reasons including being unwell, hospital appointments or simply 
forgetting the procedure. However, when they came for their monthly 
appointments it was confirmed with every subject that they had 
ejaculated 4 times since their last visit and that it was generally on a 
weekly basis. 
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4.6.1.5 Monthly visit for study arm subjects 
 
All subjects in the study arm were required to attend for monthly 
evaluations of their semen and to ensure that they were following the 
protocol. However, a number of subjects lived at some distance from 
the hospital. Hence, it was not always practical for them to come to 
the hospital. A total of 6 out of 12 subjects in the study arm did not 
come for the monthly visit. However, all attended for the final visit at 
3 months and confirmed that they had been performing VE on a 
weekly basis for the duration of the study.     
 
4.6.1.6 Drop out of subjects 
 
A total of 9/34 (26%) subjects dropped out from the study. This rate 
may be considered somewhat high but as mentioned above the SCI 
men have complex needs and require regular input from health care 
personnel. Only 3 of these subjects did not comply with the protocol 
without any valid reason. All others were either unwell or stopped 
ejaculating. 
 
4.6.2 Preparation and analysis of semen samples   
 
The semen from SCI men can be very thick and lumpy and may take 
long time to liquefy. However, no significant problems with 
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liquefaction were encountered. An additive medium was not used to 
facilitate this process as this might have affected the sample. 
Similarly, sperm count in SCI men is much below normal. It is 
recommended in WHO guidelines that if the sperm concentration is 
very low then the sample can be centrifuged and a known volume of 
seminal plasma removed. Sperm count is then performed but the 
final concentration is corrected to adjust for the removal of seminal 
plasma. Since the facility centrifugation was not available, it was 
decided to perform sperm count on the sample available. As this was 
consistent for all the cases in both arms, it was felt that this would not 
affect the outcome of results. 
Sperm motility and morphology could also be performed in the 
centrifuged sample. In this study, however, the analysis was 
performed on the original sample after preparation according to the 
WHO guidelines but without centrifugation in any case.  
 
4.6.3 Blinding of the observers 
 
It was not possible to blind the observers examining the semen 
samples as this was performed by the investigators. It was not 
possible to devise a way to collect the semen sample anonymously 
as the subjects were booked to come for VE under the supervision of 
the investigators. The semen sample was analysed in the laboratory 
by the investigators soon afterwards. As the WHO guidelines were 
followed in preparing 2 slides by two separate observers. They 
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evaluated the semen samples independently and the final result was 
reached as per the WHO recommendations. It was felt that adhering 
to the guidelines would minimise the bias in the final results. 
 
4.6.4 Success with vibro-ejaculation   
 
The success rate for VE in the study was 53%. This is lower than 
65% and above in other studies. One of the reasons could be that 
this study did not look for retrograde samples. This is possible and 
indeed, some of the subjects labelled as non-responders did report a 
milky white discharge at the next urine sample. However, it was 
decided for the purpose of the study that only the subjects who 
demonstrated clear evidence of antegrade ejaculation would be 
recruited for 2 main reasons: there would be certainty that the subject 
had ejaculated and more importantly, there would not be a need to 
deal with a urine contaminated semen sample whilst performing the 
analysis. This could have caused problems with standardising the 
results. Hence, it is accepted that the reported success rate with VE 
might be lower than other studies, but it is emphasised that this was 
to ensure production of an antegrade sample of semen.   
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4.7 Future implications 
 
This is the first study in the literature evaluating the effects of 
repeated ejaculations following SCI in men in a randomised 
controlled fashion. A semen analysis was performed for 3 months 
like most of the previous studies apart from Sonksen in 1999(115) 
who performed the study for 1 year.    
 
4.7.1 The importance of finding statistical changes 
 
In this study, morphology and forward progression improved 
significantly over the study period. Sperms have to be normal 
morphologically to demonstrate good motility. It is known that sperm 
motility and viability is much higher if aspirated from the vas deferens 
of SCI men(178). It has also been shown that sperms from able 
bodied men are inhibited when mixed with seminal plasma of SCI 
men (150). On the other hand, the same study demonstrated that 
seminal plasma from able bodied men improve the motility of sperms 
from SCI men. Hence, it can be postulated that stagnation of sperms 
in the accessory glands during the maturation phase in the 
epididymis and storage in the seminal vesicles can lead to 
deterioration of quality of sperms. It can be hypothesised that 
repeated ejaculations might improve the quality of sperms by 
decreasing the exposure of sperms to this abnormal environment. 
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4.7.2 Significance of unchanged parameters 
 
It is well known that the most important characteristic of sperms is 
motility with forward progression if successful fertilization of an ovum 
is to take place. It remains to be seen if motility can be improved with 
repeated VE over a longer period in randomised controlled studies, 
although the literature is unclear on this issue. Hence, it is felt that a 
large multicentre trial should be undertaken to answer this question. 
   
4.7.3 Role of seminal plasma in poor sperm quality in SCI men 
 
There is growing evidence that seminal plasma plays a major role in 
the deterioration of sperms following SCI in men. However, only a 
few studies have tried to investigate this issue. This institution, in 
collaboration with others, has recently pointed out specific 
biochemical abnormalities especially uridine(158) in the seminal fluid 
of SCI men. A comparison has also been made between the 
biochemical substances in the seminal fluid of infertile men with SCI 
and age-matched controls(181).  
 It is felt that newer techniques of imaging like nuclear resonance 
imaging should be utilised to evaluate the seminal plasma in SCI 
men at various stages following injury to gain insight into the causes 
of poor sperm quality 
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4.7.4 The role of repeated ejaculations in improving sperm 
quality within home settings – yet undefined 
 
It is recommended that the SCI men should start with VE and home 
vaginal insemination programme. The first step in this direction is to 
determine that they have sperms in the ejaculate. It has been 
recommended that there should be at least 4 million motile sperms in 
the ejaculate (160). However, recently, Sonksen et al (182) have 
reported that men with a motile count of less than 1 million can also 
achieve home pregnancies with home insemination programme. It 
can be suggested that these SCI men should undergo repeated VE 
as the initial step in the management of poor quality sperms over a 
period of time that is still to be determined.  The home insemination 
programme should be instituted in all cases where a reasonable 
quality ejaculate can be obtained. The success of this method can 
help with the psychological well being of SCI men and help them to 
achieve some sense of normality. This can be an important aspect of 
the rehabilitation process.  
 
4.7.5 Cost implications 
 
A doctor’s prime responsibility is always to provide the best possible 
treatment for the patients. In the current age of rising costs of 
medical care this takes on an additional importance. It is felt that if 
sperm quality can be improved with repeated VE then the cost of 
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achieving pregnancy in a home environment is much less as 
compared to the assisted techniques to which one has to resort if this 
method fails. Although, it has to be emphasised that the best quality 
health care is the one that is tailored to individual patients’ needs and 
desires. This has particular relevance for fertility issues as the age of 
the partner is of critical importance in deciding the best method of 
achieving pregnancy in childless couples. 
 
4.7.6 Need for a large multicentre randomised control trial 
 
It is proposed that a large multicentre randomised control trial should 
be undertaken. It is suggested that the study should evaluate the 
effects of repeated ejaculations on the semen in SCI men. 
Furthermore, it is recommended that the seminal plasma should be 
evaluated by nuclear resonance imaging to see if the constituents 
change with repeated ejaculations. It is felt that this experiment will 
provide critical insight into understanding the basis of poor semen 
quality in SCI men.  
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4.8 Conclusions 
 
The SCI men have unique semen characteristics with a normal count 
but very low motility and abnormal morphology. The situation is 
compounded by denervation of accessory glands probably 
contributing to further deterioration of sperm quality. The sperms can 
be obtained by either VE or EEJ in more than 95% of cases. These 
techniques should be employed before resorting to surgery.  
 
This is the first randomised control trial evaluating the effects of 
repeated vibro-ejaculation in SCI men. It has demonstrated that 
repeated ejaculations on a weekly basis for 3 months in SCI men 
significantly improves the morphology and forward progression of 
sperms. However, there was no significant improvement in the 
primary variable evaluated; sperm motility. The volume of semen and 
count of sperms also did not demonstrate any significant changes. 
The success rate for VE with optimised parameters was 53% but it 
has to be stressed that this was with a production of an antegrade 
sample. The only factor predicting a successful outcome with VE was 
an incomplete injury. The age of the patient, level of injury and the 
method of bladder management did not predict a successful outcome 
for VE. There were no significant adverse events encountered during 
the duration of the study. 
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Hence, it is recommended that VE should be the initial method of 
sperm retrieval in SCI men. If the sperms are of poor quality then the 
patient could undergo a period of repeated VE on a weekly basis, the 
duration of this is yet undefined and the benefit not certain at the 
time, but is cost effective and is close to the natural process of 
procreation. If this fails then other assisted fertility techniques can be 
applied. Thankfully, the pregnancy rate is similar in SCI men as that 
from non SCI men with male factor infertility.  
 
4.9 Future Research 
 
It is strongly recommended that further research needs to be 
undertaken in earnest in large multicentre randomised trials to 
establish the exact cause of deterioration of sperms in SCI men. 
Importantly, the role of seminal plasma and accessory glands need 
to be critically evaluated in this respect.  
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APPENDIX I 
 
 
Reference Range for normal semen analysis 
Semen parameter Value 
Volume (ml) 2.0 or more 
 PH 7.2 or more 
Count (million/ml) 20 or more 
Motility (% ) 50% or more 
Morphology (%) normal 50% or more 
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APPENDIX II 
 
Inclusion Criteria 
 
• Patient should be willing to participate in the study. 
• All participants in the study arm shall be willing to perform vibro-
ejaculation at weekly intervals for the duration of the study. 
• They will agree to come to hospital on a monthly basis for semen 
analysis. 
• The spinal cord injury should be of more than six months duration. 
• They should be able to ejaculate with vibro-ejaculation only. 
• The level of injury is above T10. 
 
Exclusion Criteria 
 
• Subjects requiring methods other than vibro-ejaculation i.e electro-
ejaculation for ejaculation. 
• Subjects getting repeated “Autonomic Dysreflexia.”  
• Subjects getting Recurrent Urinary Tract Infections. 
• Subjects who have had ejaculations since the injury. 
• The level of injury is below T10. 
• The duration of injury is less than six months. 
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APPENDIX III 
 
PATIENT INFORMATION SHEET 
FOR 
PARTICIPATION IN A CLINICAL STUDY TO EVALUATE THE 
EFFECTS OF REPEATED EJACULATIONS ON THE QUALITY OF 
SPERMS IN PATIENTS WITH SPINALCORD INJURIES 
 
Many thanks for taking time to read this information sheet regarding 
participation in this clinical trial. 
 
As you know fertility is generally poor in patients with spinal cord 
injuries. Only 5-10% of the patients can ejaculate after spinal injury 
regardless of the level. Even after assisted ejaculation the quality of 
the sperms is consistently poor. This is thought to be the most 
important factor for low fertility rate in spinally injured patients. Some 
investigators have suggested that “repeated ejaculations can 
improve the quality of sperms in patients with spinal cord injuries.” 
 
We are planning to test this theory in a randomised controlled trial. 
 
We are inviting people who have been injured for more than six 
months and the level of injury is above T10 to participate in this 
study. They should not have ejaculated after the injury. 
 
As you fulfil these basic criteria we hope that you will agree to take 
part in this study. 
 
If you are willing to participate in this study, we will have the following 
expectations of you: 
1- Randomly assigned to either the treatment or the control group. 
2- If in the study group vibro-ejaculate at weekly intervals for three 
months. 
3- If in the control group then no ejaculations till the end of study. 
4- Consent to semen analysis regardless of the group. 
5- You will be required to come to the hospital for semen analysis at 
monthly intervals if in the study group, but at the start and the end of 
the trial if in the control group. 
6- consent for semen to be analysed to ascertain associated causes 
of infertility in spinal cord injuries. 
 
You will be paid the travelling expenses when coming for the semen 
analysis and visits associated with this project. 
 
The potential side effects can be “Autonomic Dysreflexia” or Bruising 
of the penis with the Vibrator alongwith pain or discomfort. We plan 
to give you Nifedipine 20-30 minutes before the procedure to 
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minimise the risk of going autonomic. Moreover we perform 
vibroejaculate with a condom on reduce the chances of bruising.    
 
You will appreciate that low fertility rate is a very important issue in 
spinal cord injured patients. If it can be proven that with this simple 
method we can improve the quality of sperms then it can have major 
impact in increasing the fertility rate.  
 
We hope that you will agree to participate in this project. However we 
would like to make it clear that if you decide not to participate or 
withdraw at any time after enrolling in the study without assigning any 
reason, your normal care and management will not be affected. 
Moreover this study may not benefit you directly. 
 
 
If you have any queries or want to discuss any part of the project 
please do not hesitate to contact me on telephone 020 954 2300 ext. 
5608 or 5606. You can also contact Sister Liz Banbury, our specialist 
Nurse for sexual health via the switchboard. 
 
Once you decide to enter the study then we will provide you with a 
direct telephone number for use in emergencies related to this 
project.  
 
 
I hope to hear from you soon. 
 
 
Yours sincerely  
 
 
 
Rizwan Hamid 
Registrar Neuro-Urology 
Spinal Injuries Unit 
Royal National Orthopaedic Hospital 
Stanmore 
HA7 4LP  
Tel:  0208 954 2300 ext 5608 
Fax:0208 909 5343 
Mobile: 07931 760954 
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APPENDIX IV  
 
CONSENT FORM 
 
Agreement to participate in a clinical investigation 
 
CLINICAL STUDY TO DEMONSTRATE IF REPEATED 
EJACULATIONS IMPROVE THE QUALITY OF SPERMS IN 
PATIENTS WITH SPINAL CORD INJURIES. 
 
Investigators:  Professor MD Craggs, Director of Spinal Research 
Centre 
    Mr PJR Shah, Clinical Supervisor & Consultant 
    Dr F Middleton, Consultant in Rehabilitation Medicine 
  Mr R Hamid, Clinical Research Fellow in Neuro-urology 
     Sr Nurse H Bywater, Clinical Nurse Specialist 
 
1. I have read the information sheet concerning this study and I 
understand what will be required of me if I take part in this study. 
 
2. My concerns regarding this study have been answered 
by........................... 
 
3. I understand that at any time I may withdraw from this study 
without giving a reason and without affecting my normal care and 
management. 
 
4. I understand that the information from this study may be published 
in scientific journals, but that I will not be identified. 
 
5. I agree to take part in this study.  
 
 
Patient’s signature .......................................................................... 
 
Name in BLOCK LETTERS .......................................................... 
 
Date ................................................................................................ 
 
Doctor’s signature .......................................................................... 
 
Name in BLOCK LETTERS .......................................................... 
 
Date ................................................................................................ 
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APPENDIX V 
 
Papanicolaou staining procedure modified for spermatozoa  
(adapted from WHO manual) 
 
The Papanicolaou stain distinguishes clearly between basophille and 
acidophilic cell components and allows a detailed examination of the 
nuclear chromatin pattern. Although this method has been used for 
routine diagnostic cytology, the standard Papanicolaou method for 
vaginal cytology gives poor results when applied to spermatozoa. 
The present modified staining technique has proved useful in the 
analysis of sperm morphology.  
Preparation of specimen  
The smear should be air-dried and then fixed in equal parts of 95% 
ethanol and ether for 5-1 5 minutes.  
Staining procedure  
Fixed smears should be stained by the following procedure:  
ethanol 80%     10 dips 
ethanol 70%                                             10 dips 
ethanol 50%                                             10 dips 
distilled water (deionized, demineralized)10 dips  
Harris's or Mayer's haematoxylin             3 minutes exactly                    
running water                                           3-5 minutes                                   
acid ethanol                                             2 dips  
running water                                           3-5 minutes                                 
distilled water                                           1 dip  
ethanol 50%                                             10 dips                                       
ethanol 70%                                             10 dips                                       
ethanol 80%                                             10 dips                                       
ethanol 90%                                             10 dips  
Orange G6'                                               2 minutes                                   
ethanol 95%                                             10 dips                                       
ethanol 95%                                             10 dips  
ethanol 95%                                             5 dips                                         
ethanol 95%                                             5 dips                                           
ethanol 95%                                             5 dips  
ethanol 99.5%                                          2 minutes  
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APPENDIX VI 
DATA COLLECTION PROFORMA 
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APPENDIX VII 
Safety requirements the andrology laboratory (Adapted from WHO 
manual) 
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APPENDIX VIII 
 
Graph for accurate assessment of sperm motility (WHO manual) 
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APPENDIX IX 
 
Graph for accurate assessment of sperm count (WHO manual) 
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APPENDIX X 
Picture from WHO manual demonstrating the abnormal 
morphological forms of a sperm 
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